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A cell biological determination of Integrator subunit localization 
 
Sarah Beth May, B.S. 
 
Supervisory Advisor: Eric Wagner, Ph.D. 
 
 Uridine-rich small nuclear (U snRNAs), with the exception of the U6 snRNA, 
are RNA polymerase II (RNAPII) transcripts.  The mechanism of 3’ cleavage of 
snRNAs has been unknown until recently.  This area was greatly advanced when 
12 of the Integrator complex subunits (IntS) were purified in 2005 through their 
interaction with the C-terminal domain (CTD) of the large subunit (RpbI) of RNAPII.  
Subsequently, our lab performed a genome-wide RNAi screen that identified two 
more members of the complex that we have termed IntS13 and IntS14.  We have 
determined that IntS9 and 11 mediate the 3’ cleavage of snRNAs, but the exact 
function of the other subunits remains unknown.  However, through the use of a U7 
snRNA-GFP reporter and RNAi knockdown of the Integrator subunits in Drosophila 
S2 cells, we have shown that all subunits are required for the proper processing of 
snRNAs, albeit to differing degrees.  Because snRNA transcription takes place in 
the nucleus of the cell, it is expected that all of the Integrator subunits would exhibit 
nuclear localization, but the knowledge of discrete subnuclear localization (i.e. to 
Cajal bodies) of any of the subunits could provide important clues to the function of 
that subunit.  In this study, we used a cell biological approach to determine the 
localization of the 14 Integrator subunits.  We hypothesized that the majority of 
vii 
the subunits would be nuclear, however, a few would display distinct 
localization to the Cajal bodies, as this is where snRNA genes are localized 
and transcribed.  The specific aims and results are: 1. To determine the 
subcellular localization of the 14 Integrator subunits.  To accomplish this, 
mCherry and GFP tagged clones were generated for each of the 14 Drosophila and 
human Integrator subunits.  Confocal microscopy studies revealed that the majority 
of the subunits were diffuse in the nucleus, however, IntS3 formed discrete 
subnuclear foci.  Surprisingly, two of the subunits, IntS2 and 7 were observed in 
cytoplasmic foci.  2. To further characterize Integrator subunits with unique 
subcellular localizations.  Colocalization studies with endogenous IntS3 and Cajal 
body marker, coilin, showed that these two proteins overlap, and from this we 
concluded that IntS3 localized to Cajal bodies.  Additionally, colocalization studies 
with mCherry-tagged IntS2 and 7 and the P body marker, Dcp1, revealed that these 
proteins colocalize as well.  IntS7, however, is more stable in cytoplasmic foci than 
Dcp1.  It was also shown through RNAi knockdown of Integrator subunits, that the 
cytoplasmic localization of IntS2 and 7 is dependent on the expression of IntS1 and 
11 in S2 cells.  
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Small Nuclear RNAs 
 Uridine-rich small nuclear (U snRNAs) are a class of ubiquitously expressed 
small non-coding RNAs present in all cells. These critical RNAs assemble with 
proteins to form small nuclear ribonucleoproteins (snRNPs) and act in concert with 
RNA polymerase II (RNAPII) to remove introns from pre-mRNAs and process the 3’ 
end of histone mRNAs [1, 2].  They include the U1, U2, U4, U5, and U6 snRNAs of 
the major spliceosome, the U4atac, U6atac, U11, and U12 snRNAs of the minor 
spliceosome, and the U7 snRNA required for histone 3’ end processing [3-5].  All of 
these RNAs, with the exception of the RNAPIII-transcribed U6 and U6atac snRNAs, 
are transcribed by RNAPII [6, 7]. 
 The snRNA genes can be divided into two classes, the Sm-class consisting 
of the U1, U2, U4, U4atac, U5, U7, U11, and U12 snRNAs, and the Lsm-class 
consisting of the U6 and U6atac snRNAs.  The Sm-class snRNAs have a 5’-
trimethylguanosine cap, a 3’ stem loop, and an Sm site that serves as the binding 
site for the seven Sm proteins.  The Sm-class snRNAs are arranged in a similar 
manner to mRNA genes and a complex of proteins called the Integrator complex 
carries out their 3’ end formation.  In contrast, the Lsm-class snRNAs, U6 and 
U6atac, have a monomethylphosphate cap on their 5’ ends and a 3’ stem loop 
followed by a stretch of uridines that serves as the binding site for the ring of Lsm 
proteins.  This stretch of uridines also serves as a RNAPIII transcription terminator 
[1].   
 Multiple copies of the snRNA genes are present in the genome, and they are 
typically found in clusters [8-10].  The genes are much simpler than their mRNA-
3 
encoding counterparts, having no introns or 3’ polyadenylation as well as lacking a 
TATA box and an open reading frame [11].  Instead, the promoter contains two 
alternative elements, a distal sequence element (DSE) that acts as a transcriptional 
enhancer, and a proximal sequence element (PSE) that is required for snRNA 
transcription [12].  At the 3’ end of the gene, the 3’ box, with the sequence GTTTN0-
3AAAPuNNAGA where N is any nucleotide and Pu is a purine, lays 9-19 nucleotides 
downstream of the 3’ cleavage site of the mature snRNA and is required for the 
proper formation of the snRNA [13-15].  A comparison of a snRNA gene to a typical 
mRNA gene is shown in Figure 1. 
 
3’ End Formation of RNA Polymerase II Transcripts 
 The 3’ end formation of the major RNAPII transcripts: poly(A)+ mRNAs, 
histone mRNAs, and snRNAs are similar in many ways, with a few key differences 
(Figure 2).  The poly(A)+ pre-mRNAs contain two cis-elements defining their 3’ 
ends.  The first is the AAUAAA polyadenylation signal (PAS), and the second is the 
G/U rich downstream element (DSE) [16].  To form the 3’ end, the Cleavage and 
Polyadenylation Specificity Factors (CPSFs) are recruited through the binding of 
CPSF160 to the PAS [17].  CPSF160 is the only member of the core CPSFs that 
possesses an RNA binding domain. The Cleavage-Stimulation Factor (CstF) is also 
recruited to the 3’ end through the binding of CstF64 to DSE [18].  Once these two 
complexes are in place, they recruit a cleavage factor, which is comprised of 
CPSF73 and CPSF100 along with the large scaffolding protein, Symplekin.  
CPSF73 contains both a β-CASP and a β-lactamase domain that, together, cleave  
4 
 
 
 
 
 
 
 
 
Figure 1: Human snRNA genes vs. mRNA genes.  mRNA genes contain a 
promoter, an open reading frame (ORF) and a polyadenylation signal (PAS) 
marking their 3’ end.  In contrast, snRNA genes have a distal sequence element 
(DSE) and a proximal sequence element (PSE) not found in typical mRNA 
promoters.  They also lack an ORF and have a 3’ box marking their 3’ ends in lieu 
of a PAS, as snRNAs are not polyadenylated. 
 
 
 
 
 
 
 
 
 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
 
 
 
 
 
 
Figure 2: A comparison of the 3’ end formation of three major RNAPII 
transcripts.  Poly(A)+ mRNA and histone mRNA are both cleaved by CPSF73 and 
100 to form their 3’ ends.  The difference between these two transcripts lies in the 
cis- and trans-factors that recruit the cleavage factor to the cleavage site.  snRNAs, 
however, are cleaved by a novel complex of proteins called the Integrator Complex 
where the cleavage is carried out by IntS11 and 9, which show homology to 
CPSF73 and 100 respectively.  No Integrator protein resembling Symplekin has yet 
been identified [2]. 
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the mRNA at a CA cleavage site [16, 19, 20].  A polynucleotide tail of approximately 
250 adenine residues is then added by poly(A) polymerase to produce the mature 
mRNA. 
 3’ end formation of histone mRNAs is very similar to that of poly(A)+ mRNAs, 
the differences lying in the cis-elements that define the 3’ end and the lack of a 
poly(A) tail [21].  Histone mRNAs have a stem loop upstream of the cleavage site 
that is bound by the stem-loop-binding protein (SLBP) and a histone downstream 
element (HDE) that base pairs with the U7 snRNA of the U7 snRNP [22, 23].  Once 
these factors have been recognized, the same cleavage factor that cleaves 
poly(A)+ mRNA, CPSF73/ CPSF100, and Symplekin, are recruited to cleave the 
histone mRNA [24-26].  Aside from the addition of the 7meGuanosine cap, this is 
the only mRNA processing reaction that histone mRNA’s undergo as they are not 
polyadenylated. 
 Similarly to histone mRNA genes, snRNA genes also possess a stem loop 
upstream of the 3’ cleavage site, however, in place of the HDE snRNA genes 
possess the poorly conserved 3’ box [13].  The 3’ box along with the snRNA 
promoter, and the C-terminal domain (CTD) of the largest subunit (Rpb1) of RNAPII 
are all required for proper 3’ end formation [15, 27-30].  The transcription cycle of 
snRNA genes is highly related to standard mRNA genes with some key exceptions.  
When an snRNA gene is going to be transcribed (Figure 3), RNAPII is recruited to 
the promoter by the binding of an snRNA-specific complex of proteins termed the 
PSE-binding transcription factor (PTF) (also called snRNA activator protein complex 
(SNAPc) and PSE-binding protein (PBP)) [11].  Once recruited to the promoter, the  
9 
 
 
 
 
 
 
 
Figure 3: The Integrator complex mediates snRNA 3’ end processing.  The 
Integrator complex is recruited to an snRNA gene via phosphorylation of the CTD at 
serines 2 and 7 of RNAPII.  It then rides along as RNAPII transcribes the snRNA 
and is transferred to the nascent snRNA at the 3’ box.  Upstream of the 3’ box, the 
snRNA is cleaved by IntS11 and 9, which display homology to CPSF73 and 100 
respectively [36]. 
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CTD of RNAPII, which contains multiple repeats of the heptad YS2PTS5PS7, is 
phosphorylated at the serine 2 and serine 7 positions of the heptad through the 
activity of multiple kinases [31, 32].  The serine 2 kinase cdk9/cyclin T has been 
shown to be required for snRNA 3’ end formation and appears likely to be one of 
the CTD kinases required.  The identity of the serine 7 kinase is more controversial 
as both TFIIH and DNA-PK have been shown to possess this activity.  Importantly, 
neither of these kinases has been shown to be functionally required for snRNA 3’ 
end formation.  This phosphorylation is thought to then recruit a recently purified 
complex of proteins called the Integrator complex to the CTD of RNAPII [33, 34].  
The Integrator complex is speculated to associate with RNAPII as it transcribes, and 
is transferred to the nascent snRNA at the 3’ box.  Once at the 3’ box, cleavage is 
carried out upstream by Integrator subunits (IntS) 11 and 9, which exhibit homology 
to CPSF73 and CPSF100 respectively [33, 35, 36].  Interestingly, it has not been 
shown that Symplekin or a Symplekin-like protein is a member of the Integrator 
complex or that any of the Integrator subunits display any homology to Symplekin, 
nor is in known how the Integrator complex mediates snRNA cleavage [2]. 
 
The Integrator Complex 
 In 2005, the Shiekhattar laboratory discovered the Integrator complex in a 
pull-down experiment to find proteins that interacted with the Deleted in Split 
hand/Split foot (DSS1) protein.  They purified the complex and found that it was 
comprised of 12 subunits and associated with the CTD of the largest subunit (Rpb1) 
of RNAPII [33].  Subsequent purifications performed by the Shiekhattar laboratory, 
12 
in which they use flag-tagged IntS10 to pull down and purify the complex as well as 
a more recent purification by a separate group using specific antibodies against 
Integrator subunits failed to pull down DSS1, showing that its ability to pull down the 
Integrator complex in the first purification was serendipitous and it is not in fact a 
member of the Integrator complex [33, 37].  
In addition to its interaction with the CTD, it was also shown that the 
Integrator complex mediates 3’ end processing of snRNAs through the use of RNA 
interference (RNAi).  When IntS11 or IntS1 was knocked down via RNAi, an 
accumulation of misprocessed snRNA, which migrates slower than normal snRNA, 
and is therefore longer, was observed via Northern blot.  This is evidence that when 
the Integrator complex is compromised, primary snRNAs are not cleaved properly at 
the 3’ end, longer misprocessed forms are allowed to accumulate, leading to the 
conclusion that the Integrator complex mediates snRNA 3’ end processing [33].   
The involvement of the Integrator complex was further demonstrated in a 
study by the Wagner laboratory in which a reporter system was developed in 
Drosophila S2 cells that placed the green fluorescent protein (GFP) gene and a 
PAS downstream of the 3’ box of the U7 snRNA gene.  When transfected into 
normal cells, any U7 snRNAs transcribed from the reporter plasmid will be cleaved 
upstream of the 3’ box and no GFP will be expressed.  However, when the reporter 
is transfected into cells in which the Integrator complex has been compromised 
through RNAi of Integrator subunits, the U7 snRNA will not be properly cleaved.  As 
a result, RNAPII will read-through to the PAS and GFP will be expressed in these 
cells, indicating that snRNAs are being misprocessed.   With this tool, it was shown 
13 
that depletion of each Integrator subunit causes misprocessing of snRNAs, albeit to 
differing degrees.  It was observed that knockdown of IntS1, 4, and 9 caused strong 
expression of GFP and therefore high misprocessing of snRNA, knockdown of 
IntS5, 7 and 11 yielded and intermediate response, knockdown of and IntS2, 6, 8, 
10, and 12 a weak response, while the knockdown of IntS3 resulted in no 
detectable misprocessing.  The group confirmed these results using a RT-PCR 
assay with forward primers designed to the U7snRNA and reverse primers 
designed downstream of the cleavage site [38].  In addition to the Drosophila 
assays, the Wagner laboratory has also developed similar human assays that are 
yielding similar results.      
 As mentioned previously, two Integrator subunits, IntS11 and 9 bear 
homology to CPSF73 and 100, the cleavage factor for poly(A)+ mRNAs and histone 
mRNAs [33, 35].  This is especially true in the β-CASP and β-lactamase domains 
present in both sets of proteins, where the amino acid sequences of core elements 
within IntS11/CPSF73 and IntS9/CPSF100 are almost exactly alike.  Both IntS11 
and CPSF73 contain a β-CASP (metallo-β-lactamase-associated CPSF Artemis 
SNM1/PSO2) β-lactamase domain, which is essentially a β-lactamase domain that 
has been modified to allow the endonucleolytic cleavage of nucleic acids.  IntS9 and 
CPSF100 also contain a β-CASP β-lactamase domain, however, it has been 
modified so as to render it inactive [2, 35].  Baillat et al. determined that IntS11 was 
the catalytic subunit of the Integrator complex by overexpressing a mutant IntS11 
that lacked catalytic activity in the β-CASP domain.  However, it still interacted with 
other Integrator subunits and was shown to localize to snRNA genes at both the 
14 
promoter and the 3’ end.  When the mutant IntS11 was overexpressed following 
depletion of endogenous IntS11, sizable amounts of misprocessed snRNA were 
observed, leading to the conclusion that IntS11 is in fact the subunit responsible for 
snRNA cleavage [33]. 
 When it was first purified, the Integrator complex was thought to consist of 12 
subunits, however, a genome wide RNAi screen preformed in Drosophila S2 cells 
found two more subunits, bringing the total up to 14.  The complex is evolutionarily 
conserved among metazoans; however, there are no Integrator orthologues in the 
yeast Saccharomyces cerevisiae as the Nrd1/Nab3/Sen1 complex mediates snRNA  
3’ end formation in this species [2, 39, 40].  A schematic of the 14 Integrator 
subunits mapping domains identified by Pfam analysis (in green) is shown in Figure 
4.  In addition to the β-CASP β-lactamase domains found in IntS9 and 11, the only 
other identifiable domains to be found in the complex are the armadillo repeats 
(ARM) found in IntS4 and 7, the HEAT repeats found in IntS4, the von Willebrand 
factor A domains found in IntS6 and 14, the RNA DEAD box helicase (DEAD) (likely 
inactive, as key residues are mutated) also in IntS6, the tetratricopeptide repeats 
(TPR) in Int8, and the plant homeodomain (PHD) finger in Int12.  Armadillo, HEAT, 
and TPR repeats as well as von Willebrand factor A domains are all involved in 
protein-protein interactions as well as intracellular transport, and the PHD finger is a 
chromatin binding domain.  The domain of unknown function (DUF) regions are 
areas that Pfam has identified as functional domains, however, the exact function of 
these regions is unknown.  Surprisingly, none of the subunits display any known 
RNA binding domains [2].   
15 
 
 
 
 
 
 
 
 
 
Figure 4: Schematic of Integrator complex subunits.  The areas shaded in 
green are protein domains identified through Pfam analysis.  Areas in orange are 
areas of high homology.  Surprisingly, none of the domains identified are known 
RNA binding domains [2]. 
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 Since its purification, many members of the Integrator complex have been 
implicated in other studies, either for their role in snRNA expression, or for other 
functions, suggesting that Integrator proteins may play roles in other processes.  
For example, knockdown of IntS1 in mouse embryos results in lethality, and further 
examination of the embryos shows an increase in misprocessed snRNAs [41].  
Another study has shown that when IntS5 expression is inhibited in zebrafish they 
fail to develop circulating blood cells.  This is because the lack of functional snRNAs 
brought on by the disruption in the Integrator complex leads to splicing defects in 
the mRNAs of proteins necessary for hematopoeisis [42].  IntS3 has been shown to 
function as part of the sensor of single-stranded DNA (SOSS) complex responsible 
for the detection of double-stranded breaks in DNA, and IntS6 has been determined 
to be a previously described tumor suppressor gene discovered in non-small-cell-
lung carcinoma, deleted in cancer 1 (DICE1), which, when overexpressed in 
prostate cancer cells leads to a reduction in colony formation and cell cycle arrest 
[43-46].  These studies suggest the possibility that some Integrator subunits may 
also play role in cellular processes other that snRNA expression. 
 
snRNP Biogenesis    
 All U snRNAs are members of the U small nuclear ribonucleoproteins 
(snRNPs), the majority of which function as part of the major and minor 
spliceosomes that excise introns out of pre-mRNAs.  The exception is the U7 
snRNP, which plays a role in the 3’ end formation of histone mRNAs.  A brief 
description of snRNP biogenesis (Figure 5) begins in the nucleus with the  
18 
 
 
 
 
 
 
 
Figure 5: The biogenesis of U snRNPs.  snRNP biogenesis begins in the nucleus 
with the transcription of snRNAs, usually associated with a Cajal body.  The snRNA 
is then transported out of the nucleus to the cytoplasm where snRNP proteins are 
assembled onto the snRNA by the survival of motor neurons (SMN) complex.  Once 
the proteins are properly assembled, the snRNP is then transported back to the 
nucleus were it first returns to the Cajal body for further processing and is then 
transported to the nuclear speckles to participate in splicing [47]. 
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transcription and 3’ end formation of the snRNAs.  The snRNAs are then 
transported into the cytoplasm of the cell where a complement of proteins is 
assembled onto the snRNA to form a preliminary snRNP.  The snRNP is then 
transported back to the nucleus for further processing before it assumes its function 
as part of the spliceosome [47].  This is the case for all of the U snRNPs with the 
exception of the U6 snRNP whose assembly takes place solely in the nucleus [48, 
49].  A more detailed account of snRNP biogenesis is given below.  
 As stated previously, snRNA genes, usually found clustered adjacent to Cajal 
bodies [50] are transcribed by RNAPII to begin the snRNP biogenesis process.  A 
complex of proteins called the cap-binding complex (CBC), which consists of the 
proteins CBP20 and CBP80, associates co-transcriptionally with the 5’ 7-
methylguanosine (7mGpppN) cap of the snRNA [51].  Next, an adaptor protein 
termed phosphorylated adaptor for RNA export (PHAX) binds to the CBC.  PHAX 
contains a leucine-rich nuclear export signal (NES) that is only active when PHAX is 
phosphorylated [52].  Once a phosphorylated PHAX is bound to the snRNA, 
Chromosome Region Maintenance 1 (CRM1), a nuclear export factor, binds to the 
exposed NES of PHAX along with the small G-protein, RanGTP, and shuttles the 
snRNA out of the nucleus [47, 53]. 
 Once the complex enters the cytoplasm, PHAX is dephosphorylated by 
protein phosphatase 2A releasing CRM1 and RanGTP, however, it remains with the 
CBC/snRNA complex most likely until the monomethylated (m1G) 7mG cap is 
trimethylated (m3G cap) to prevent the snRNA from interacting with the translation 
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initiation machinery [47, 54].  The large SMN complex made up of the SMN protein, 
Gemin 2-8, and multiple other proteins then associates with the CBC/snRNA 
complex and monitors all maturation events that take place in the cytoplasmic 
phase of snRNP assembly [55, 56].  The first of these events is the assembly of the 
Sm ring around the Sm site of the snRNA.  A set of seven Sm proteins, B/B’ (B’ is a 
splice variant of B), D1, D2, D3, E, F, and G form a ring around a conserved 
sequence called the “SM binding site” (PuAU4-6GPu) upstream of the snRNA 3’ 
stem loop [57].  By themselves, the proteins exist as dimers or trimers as they 
cannot form a ring in the absence of snRNA.  To load the Sm proteins onto the 
snRNA, SMN first facilitates the formation of an open ring consisting of D1, D2, E, 
F, and G.  The SMN complex then loads this complex on to the snRNA Sm site, and 
closes the ring with the addition of the B/B’-D3 dimer.  After the Sm ring is in place, 
trimethyl guanosine synthase 1 (Tgs1), an SMN complex-associated 
methyltransferase, recognizes B/B’ and the m1G cap which prevents snRNAs 
without a complete Sm ring from being hypermethylated as the B/B’-D3 dimer is the 
last of the Sm proteins to be added to close up the ring.  Tgs1 then transfers two 
methyl groups to position 2 of the m1G cap to form the 2,2,7-trimethylguanosine 
(m3G) cap.  The 3’ end of the snRNA then undergoes further nucleolytic trimming to 
form a mature length snRNA [47, 58-61].  Snurportin-1 (SPN1) along with the import 
receptor Importin-β (Imp β) then interacts with the m3G cap and the Sm core, which 
acts as a nuclear localization signal (NLS) and imports the snRNP back into the 
nucleus [47]. 
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 Upon reentry to the nucleus, SPN1 and Imp β disassociate from the snRNP 
and return to the cytoplasm, however the SMN complex remains attached.  The 
snRNP then returns to the Cajal body, where further modifications occur, such as 
pseudouridylation and 2’-O-methylation, carried out by small Cajal body RNAs 
(scaRNAs) [62, 63].  The SMN complex disassociates from the snRNP at an as yet 
unidentified stage in the nuclear maturation process and returns to the cytoplasm, 
and the mature snRNP is recruited to subnuclear domains called nuclear speckles 
where splicosomal snRNPs are stored, or, as is the case of the U7 snRNP, to 
histone locus bodies [3, 47]. 
 
Subcellular Localizations of RNPs 
 Ribonucleoproteins (RNPs) often concentrate, both in the nucleus and the 
cytoplasm, into subcellular foci that can be visualized under a light microscope.   
While the motives and mechanism behind the formation of these foci is largely 
unclear, it is possible that they function to concentrate factors necessary for certain 
RNA processing events such as, intron splicing, 3’ end formation, transcription, and 
decay.  Because the Integrator complex is responsible for the 3’ end processing of 
snRNAs we hypothesized that some of the subunits would be present in some of 
these nuclear foci, and while this was shown to be the case, some of the subunits 
were unexpectedly shown in cytoplasmic foci as well.  Possible locations of these 
Integrator foci include, Cajal bodies, nuclear speckles, and histone locus bodies in 
the nucleus, and P bodies, stress granules, and U bodies in the cytoplasm will be 
discussed below [64-66]. 
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Cajal Bodies 
 First described in 1903 by Ramon y Cajal, Cajal bodies are dynamic, small 
nuclear bodies that are enriched with the protein coilin [65].  In addition to coilin, the 
U snRNPs are also enriched in Cajal bodies as well as the SMN complex, which 
point to a function in snRNP processing, and Cajal bodies contain small Cajal body-
specific RNAs called scaRNAs which are responsible for carrying out 2’-O-
methlyation and pseudouridylation modifications on the snRNAs of snRNPs once 
they reenter the nucleus [62, 67].  Cajal bodies have also been shown to localize to 
snRNA gene clusters [50, 68, 69], and are sites of active snRNA transcription [70].  
The Ohno laboratory has recently shown that Cajal bodies also play a role in 
snRNP assembly prior to its transport into the cytoplasm as well [71].  Their findings 
demonstrate that Cajal bodies monitor the export of snRNAs out of the nucleus after 
transcription.  When PHAX, the NES-containing adaptor protein, is blocked from 
binding to nascent snRNAs, the snRNAs are retained in the Cajal body and 
prevented from exiting to the cytoplasm [71].  Despite its standard use as a marker 
of Cajal bodies, the cellular function of coilin is unknown.  Cells lacking coilin, no 
longer form Cajal bodies, meaning coilin is necessary for Cajal body structure, 
however, snRNP modifications are carried out normally, demonstrating that Cajal 
bodies are not necessary for proper snRNP maturation [65].  In addition to snRNP 
processing, Cajal bodies are also storage sites for telomerase RNA during 
quiescent phases of the cell cycle.  During S phase, when telomeres are being 
elongated, the telomerase RNA then moves to the telomerase holoenzyme at the 
telomeres [72-74]. 
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Histone Locus Bodies 
 Histone locus bodies are so called, because they associate with the histone 
genes on chromosome 1 or 6 and are enriched for factors required for histone 
mRNA 3’ end processing, such as, the U7 snRNP, SLBP, and Symplekin [75, 76].  
The existence of these domains was revealed through experiments to visualize 
Cajal bodies in Drosophila cells.  The sequence to Drosophila coilin was not 
available at the time, so the group used probes to the U7 snRNP and the U85 
scaRNA.  These probes revealed two separate types of subnuclear foci.  The Cajal 
bodies were determined to be the ones that contained both the U7 snRNP and the 
U85 scaRNA, and the others, containing only the U7 snRNP were termed the 
histone locus bodies because of their association with histone genes [77].  As 
previously mentioned, histone locus bodies form around replication-dependent 
histone gene clusters.  These genes are only active during S phase, and it is 
thought that these nuclear bodies serve to concentrate factors necessary for the 
maturation of histone mRNAs.  The histone locus bodies are visible until early 
prometaphase and then disintegrate in metaphase.  Once the new cells enter G1 
phase, a few histone locus bodes reform, and their numbers increase upon the 
entrance of S phase [78].  Histone locus bodies are usually seen adjacent to Cajal 
bodies, however, the relationship between these subnuclear domains is unknown 
[65].     
Nuclear Speckles 
 Nuclear speckles, also known as interchromatin granule clusters (IGCs), are 
sites enriched in mature U snRNPs and function in pre-mRNA splicing.  In addition 
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to snRNPs, nuclear speckles also contain serine/arginine-rich (SR) proteins whose 
phosphorylation state regulates the interaction of the snRNPs with the spliceosome 
as well as sites of transcriptionally active genes.  Each nucleus typically contains 
approximately 30-50 nuclear speckles, which can travel around the nucleus to 
associate with actively transcribing genes [64, 66]. 
 
P Bodies 
 The cytoplasmic foci that later became known as P bodies, were first 
observed by the Achsel laboratory in 2002.  In this paper, it was shown that LSm1-
7, an mRNA decapping activator complex, Dcp1/2, a decapping enzyme, and the 
exonuclease Xrn1 all co-localize to discrete cytoplasmic foci [79].  In 2003, Sheth 
and Parker showed that many mRNA decapping and decay factors were present in 
these cytoplasmic foci in yeast, including, Dcp1p, Dhh1p, and Xrn1p and 
hypothesized that these foci either might be storage sites for mRNA decay factors, 
or sites of active mRNA decapping and decay.  They called these foci processing 
bodies, or P bodies.  If P bodies were active sites of decapping and decay, then the 
group speculated that inhibiting mRNA decay before the decapping step should 
reduce the number of P bodies.  This was because blocking decapping would 
reduce the number of mRNAs targeted for decay, and more mRNAs would remain 
in polysomes.  Conversely, blocking mRNA decay at or after decapping would 
increase the number of P bodies because the mRNA could be targeted for decay, 
however, disruption of the decay machinery would cause targeted mRNAs to 
accumulate in more and more P bodies.  Knockout experiments proved this to be 
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true.  In a ccr4Δ strain, which is deficient in deadenylation (before decapping), P 
bodies are reduced, however, in dcp1Δ (at decapping) and xrn1Δ (after decapping) 
strains P bodies increase in both size and number [80]. 
 In addition to decapping factors and exonucleases, proteins involved in other 
mRNA decay processes also accumulate in P bodies.  Proteins involved in 
nonsense-mediated decay (NMD), which is responsible for the decay of mRNAs 
with premature stop codons (nonsense codons), as well as proteins involved in AU-
rich element (ARE)-mediated decay have been found to accumulate in P bodies 
[81-85].  Additionally, the Argonaute and GW proteins involved in RNAi and 
microRNA (miRNA)-mediated gene silencing, and translational repressors such as 
eIF4E-transporter, the yeast Dhh1 and its vertebrate orthologue RCK/p54 
accumulate in P bodies [86-90]. P bodies have additionally been shown to be sites 
of replication for RNA viruses as well as sites of host viral defense [91, 92].   
 P bodies require translationally repressed mRNPs in order to form, and RNAi 
and miRNA silencing pathways produce a significant portion of these mRNPs [93, 
94].  Izaurralde and colleagues have shown that inhibition of miRNA silencing 
pathways and, to lesser extent, RNAi pathways also prevents the formation of 
visible P bodies.  However, simply releasing mRNPs from polysomes with 
puromycin treatment, which mimics an aminoacylated tRNA and triggers release of 
the mRNA from the ribosome when the drug enters the A site, is not sufficient to 
restore P bodies in cells with inhibited silencing pathways.  The mRNPs must enter 
silencing and decay pathways for P bodies to form.  Even though P bodies require 
silencing pathways to form, silencing pathways do not require P bodies to function, 
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as depletion of non-silencing P body components disrupts the formation of P 
bodies, but not the function of miRNA silencing pathways.  Therefore, P body 
formation is a consequence of silencing pathway function [94].   
 While the exact mechanism of P body assembly is unknown, many P body 
components contain Q/N rich prion-like domains, and it is hypothesized that protein-
protein interactions between these domains play a role in P body aggregation along 
with other possible mechanisms [93, 95].  Additionally, other proteins with prion-like 
domains, such as the huntingtin (Htt) protein have also recently been shown to 
accumulate in P bodies [96]. 
Stress Granules 
 Non-translating mRNPs may also form into another type of cytoplasmic foci 
called stress granules.  These granules are composed of mRNPs that are stalled in 
translation initiation as well as initiation factors eIF4E, eIF4G, eIF4A, eIF3 and eIF2, 
the small, 40S, ribosomal subunit, and the poly(A) binding protein (Pab1).  Stress 
granules form in response to environmental stresses such as heat shock, hypoxia, 
glucose deprivation, and viral infection [97].  Similar to P bodies, the exact assembly 
mechanism of stress granule formation is unknown, though self-aggregation 
domains in some components are thought to play a role in this process [98, 99].  
Stress granules are also often observed adjacent to P bodies, which lead Balagopal 
and Parker to propose a model for cytoplasmic mRNA metabolism they call the 
mRNA cycle (Figure 6) [93].  In this model, they suggest that mRNAs in the 
cytoplasm cycle between three different states: actively translating in polysomes, 
translationally repressed or decaying in P bodies, and stalled in initiation in stress  
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Figure 6: The mRNA cycle.  Balagopal and Parker have proposed a model of 
cytoplasmic mRNA metabolism whereby mRNAs are shuttled between three sites: 
polysomes, P bodies, and stress granules [93].   
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granules.  The recruitment of translational repressors, such as Dhh1 and Pat1 along 
with ribosomal run off transition the mRNA to a non-translating state.  They can then 
aggregate into P bodies where they are stored to reenter a translating state in the 
future, decapped by Dcp1/2 and degraded, or transferred to stress granules.  
mRNAs stalled in initiation aggregate in stress granules.  From here they can either 
reenter into polysomes once the stress has passed or be transferred to P bodies 
[93]. 
U Bodies 
 A third type of cytoplasmic foci is the recently described U body.  These 
granules were first observed by Liu and Gall in Drosophila nurse cells using 
immunofluorescent staining and in situ hybridization.  YFP-tagged Lsm11, an Sm 
core protein unique to the U7 snRNP, was expressed in transgenic flies, and in 
addition to the histone locus bodies found in the nucleus, the proteins were also 
observed in cytoplasmic foci.  Immunofluorescent staining using antibodies to 
endogenous Lsm11 as well as Lsm10 confirmed this result.  In situ hybridization 
was then performed using probes against U1, U2, U4, U5, and U6, snRNAs, and all 
were found to be present in these cytoplasmic foci as well.  These results led to the 
term U bodies.  U bodies were also shown to contain the SMN protein.  In addition, 
flies that are homozygous for a mutant form of the arginine methyl transferase Dart5 
lack detectable U bodies.  Dart5 is responsible for the conversion of arginine 
residues of Sm proteins to symmetrical dimethylarginine (sDMA) leading to 
enhanced interaction between SMN and the Sm proteins.  U bodies always occur in 
conjunction with P bodies although not all P bodies interact with U bodies, and 
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disruption of P bodies also leads to disruption of U bodies, suggesting a functional 
interaction between these two structures.  These data led to the proposal that U 
bodies are either sites for certain steps in snRNP assembly or sites of cytoplasmic 
snRNP storage before import into the nucleus.  P bodies might interact with U 
bodies to regulate the release of snRNPs from the U bodies to the nucleus, or they 
might be sites of decay for dysfunctional or unnecessary snRNPs [100].  
  
Summary of Work 
 This study investigates the subcellular localizations of the Integrator subunits 
and seeks to determine if any exhibit unique localizations that might lead to further 
information about their function.  The hypothesis of this work is that the majority 
of subunits will display general nuclear localization, however, a few will have 
distinct localization to the Cajal bodies, as this is where snRNA are localized 
and transcribed.  To test this hypothesis, two specific aims were addressed.  The 
first specific aim was to determine the subcellular localization of the 14 
Integrator subunits.  To do this, all Integrator subunits from both Drosophila and 
human were cloned either N-terminal or C-terminal to cDNA encoding either 
mCherry or GFP to generate fusion proteins.  These clones were subsequently 
transfected into HeLa or S2 cells and their expression and localization was then 
visualized using confocal microscopy.  The majority of the subunits were found to 
be diffusely expressed in the nucleus, however, IntS3 localized in discrete foci in the 
nucleus, and IntS2 and 7 surprisingly formed cytoplasmic foci.  The second 
specific aim was to further characterize those Integrator subunits that 
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demonstrated a unique subcellular localization.  A variety of experiments, 
including co-localization studies, deletions, and RNAi knockdowns were preformed 
with IntS2, 3 and 7, and our data suggests that IntS3 localizes to the Cajal bodies, 
consistent with its function in snRNA 3’ end processing, and while still present in the 
nucleus, both IntS2 and 7 also localize to cytoplasmic P bodies, suggesting they 
either play a role in snRNA decay or another cellular function unrelated to snRNA 
and snRNP biogenesis.  These results have demonstrated the localizations of the 
Integrator subunits, revealing unique localizations for three members of this 
complex.  Further investigation of these subunits in context of these localizations 
will lead to increased understanding of Integrator complex function in snRNA and 
snRNP biogenesis, and may lead to the discovery of Integrator involvement in other 
cellular processes. 
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Cell Culture  
 The human cervical cancer derived cell line, HeLa, was obtained from the 
laboratory of Dr. Phillip Carpenter.  These cells were maintained in DMEM 
Glutamax-1 high glucose media from Invitrogen, (Carlsbad, CA) supplemented with 
10% FBS and 1% Penicillin-Streptomycin at 37°C with 5% CO2.  D.Mel-2 (S2) cells, 
were obtained from Invitrogen, and are derived from late-stage Drosophila 
melanogaster embryos and conditioned to grow in serum free environments.  These 
cells were maintained in Sf-900 II SFM serum free media (Invitrogen) at 28°C.  E. 
coli XL1 Blue competent cells were grown in Luria broth (LB) at 37°C, and ampicillin 
was added at 50 µg/mL as needed.    
 
Transfections 
 Transient transfections of human cell lines were performed using the 
Lipofectamine 2000 transfection reagent from Invitrogen.  Briefly, cells were plated 
in 6-well plates at 2.5×105 cells/well and allowed to attach overnight.  To prepare 
the DNA for transfection, 100-500ng/well of plasmid DNA was added to 100µL/well 
of Opti-MEM reduced serum media (Invitrogen) in tube A.  In tube B 2µL/well 
Lipofectamine 2000 was mixed with 100µL/well Opti-MEM.  These tubes were 
incubated for 7 minutes after which the contents of the two tubes were mixed and 
allowed to incubate for another 25 minutes.  200µL of the DNA/Lipofectamine 2000 
solution was then added to each well to be transfected.  Transient transfections of 
the Drosophila S2 cell line were carried out using the Effectene transfection reagent 
from Qiagen (Hilden, Germany) according to the manufacturer’s protocol.  
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Cloning Reactions  
 Insert DNA was generated through PCR by using the primer sets found in 
Tables 1-5.  The amplified DNA was then purified using the GeneJET PCR 
purification system from Fermentas (now part of Thermo Scientific, Glen Burnie, 
MD) according to the manufacturer’s protocol.  Digests of the vector and insert DNA 
were carried out using Fermentas FastDigest restriction enzymes.  To digest the 
vector: 1-3µg of the vector DNA was mixed with 10µL of the 10X FastDigest buffer 
and 1µL of each restriction enzyme.  The volume of the reaction was then brought 
up to 100µL with dH2O and incubated at 37°C for 10-15 minutes.  To digest the 
insert: the PCR product eluted from the purification column (≈ 48µL) was mixed with 
6µL 10X FastDigest buffer, 4µL of dH20, and 1µL of each restriction enzyme and 
incubated at 37°C for 10-15 minutes.  Once the vector had been digested, 1µL of 
Fermentas FastAP alkaline phosphatase was added to the reaction mixture and 
incubated for an additional 10 minutes.  To purify the digested vector and insert 
DNA, it was first run on a 1% agarose gel.  The gel containing the DNA was then 
excised, and purified using the GeneJET PCR purification system.  To ligate the 
vector and insert DNA, a ligation reaction was set up consisting of 4µL of vector 
DNA, 4µL of insert DNA, 1µL of 10X ligation buffer, and 1µL of T4 DNA ligase 
(purified by the Wagner Laboratory).  A control, vector alone, reaction with dH20 in 
place of the insert DNA, was also set up at this time, and these reactions were 
incubated at room temperature for 4-24 hours.  5µL of each ligation reaction was 
then transformed into XL1 Blue competent E. coli cells and plated on LB agar plates 
containing ampicillin.  Approximately 16 hours later, 5mL cultures of picked colonies 
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were set up and allowed to grow overnight.  The plasmid DNA was recovered from 
these cultures using the Fermentas GeneJeT plasmid miniprep kit.  The plasmids 
were then screened by restriction digest using the restriction enzymes used to clone 
the plasmid.          
 
Generation of Tagged Integrator Clones 
Human clones 
 To generate the human tagged Integrator clones, mCherry and GFP cDNAs 
were first cloned into the pcDNA4/TO/myc-His A vector from Invitrogen using the 
primers listed in Table 1.  mCherry and GFP were inserted so as to create four new 
vectors to allow the fluorescent tags to be placed either N-terminal or C-terminal to 
the Integrator subunit subsequently cloned.  Inserts for the Integrator subunits were 
then prepared using the primers listed in Table 2 and were cloned into the mCherry 
and GFP vectors using the restriction sites listed.   
Drosophila clones 
 Because the commercially available pIZ/V5-His vector (Invitrogen) suitable 
for use in insect cells yields weak protein expression, a new, more robust 
expression vector was created for this project.  To do this, first, the strong 
Drosophila Ubiquitin 63E (Ubi63E) promoter [101] was cloned into the pUC 19 
vector.  Downstream of this promoter, the multiple cloning site (MCS) of the pIZ/V5-
His vector was inserted.  Finally, mCherry cDNA was cloned into the pIZ MCS to 
generate the new pUB Cherry vector (Figure 7).  The primers used for the synthesis 
of this vector are listed in Table 3.  The Integrator subunits were then cloned into  
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Table 1: Primers sets and restriction enzymes used to generate pcDNA4 N/C-
terminal mCherry and GFP vectors.   
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N-GFP F 
N-GFP R 
 
C-GFP F 
C-GFP R 
 
N-mCherry F 
N-mCherry R 
 
C-mCherry F 
C-mCherry R 
 
GGCCAAGCTTATGGTGAGCAAGGGCGAGGAG 
GGCCGGATCCCTTGTACAGCTCGTCCATGCC 
 
GGCCTCTAGAGATGGTGAGCAAGGGCGAGGAG 
GGCCACTAGTTCACTTGTACAGCTCGTCCATGCC 
 
GGCCAAGCTTATGGTGAGCAAGGGCGAGGAGGAT 
GGCCGGATCCCTTGTACAGCTCGTCCATGCC 
 
GGCCTCTAGAGATGGTGAGCAAGGGCGAGGAGGAT 
GGCCACTAGTTTACTTGTACAGCTCGTCCATGCC 
 
HindIII 
BamHI 
 
XbaI 
SpeI 
 
HindIII 
BamHI 
 
XbaI 
SpeI 
Primer 
Sets 
Primer Sequence 
(5’-3’) 
Restriction 
Site 
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Table 2: Primer sets and restriction enzymes used to generate mCherry and 
GFP tagged human Integrator subunit clones.  Stop = stop codon included in 
this primer.  Reverse primers that contain stop codons were used to generate N-
terminal clones and primers lacking stop codons were used to generate C-Terminal 
clones. 
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IntS2 F 
IntS2 R (Stop) 
IntS2 R 
 
IntS3 F 
IntS3 R (Stop) 
IntS3 R 
 
IntS4 F 
IntS4 R (Stop) 
IntS4 R 
 
IntS5 F 
IntS5 R (Stop) 
IntS5 R 
 
IntS6 F 
IntS6 R (Stop) 
IntS6 R 
 
IntS7 F 
IntS7 R (Stop) 
IntS7 R 
 
IntS9 F 
IntS9 R (Stop) 
IntS9 R 
 
IntS10 F 
IntS10 R (Stop) 
IntS10 R 
 
IntS11 F 
IntS11 R (Stop) 
IntS11 R 
 
IntS12 F 
IntS12 R (Stop) 
IntS12 R 
 
 
GGCCGCGGCCGCATGACGCCCGAGGGTACAGGC 
GGCCACTAGTCTTTAAATTCCACTAACACTCATGTT 
GGCCACTAGTCTAATTCCACTAACACTCATGTT 
 
GGCCGAATTCATGGAGTTGCAGAAGGGAAAAG 
GGCCCTCGAGCGTTAGTCACTGTCAGAGCCCACTGC 
GGCCCTCGAGCGGTCACTGTCAGAGCCCACTGC 
 
GGCCGCGGCCGCATGGCGGCGCACCTTAAGAAG 
GGCCTCTAGACTTTAGCGCCGTGCAGGTTTGGGCA 
GGCCTCTAGACTGCGCCGTGCAGGTTTGGGCA 
 
GGCCGAATTCTATGTCCGCGCTGTGCGACCCT 
GGCCCTCGAGCGCTACGTCCCCTGTCGAAGGAGAGT 
GGCCCTCGAGCGCGTCCCCTGTCGAAGGAGAGT 
 
GGCCGAATTCTATGAACCAGCGCAGCCATCTG 
GGCCTCTAGACTTTAATTGCTATTAATATGGGTGAT 
GGCCTCTAGACTATTGCTATTAATATGGTTGAT 
 
GGCCGAATTCTATGGCGTCAAACTCAACTAAG 
GGCCTCTAGACTTTAAAACCGTGTGTAGGCATT 
GGCCTCTAGACTAAACCGTGTGTAGGCATT 
 
GGCCGCGGCCGCATGAAACTGTATTGCCTGTCA 
GGCCTCTAGACTTTAGAACTTTGTAAGAATTT 
GGCCTCTAGACTGAACTTTGTAAGAATTT 
 
GGCCGCGGCCGCATGTCTGCCCAGGGGGACTGC 
GGCCTCTAGACTTTAGGTCAGAGTCTGAAGGAG 
GGCCTCTAGACTGGTCAGAGTCTGAAGGAG 
 
GGCCGGATCCATGCCTGAGATCAGAGTCACG 
GGCCTCTAGACTTTAGCTGGGGGCCTGGGGGAG 
GGCCTCTAGACTGCTGGGGGCCTGGGGGAG 
 
GGCCGGATCCATGGCTGCTACTGTGAACTTG 
GGCCTCTAGACTTTACTTCTTGAGTTTCTTTTGGGC 
GGCCTCTAGACTCTTCTTGAGTTTCTTTTGGGC 
 
NotI 
SpeI 
SpeI 
 
EcoRI 
XhoI 
XhoI 
 
NotI 
XbaI 
XbaI 
 
EcoRI 
XhoI 
XhoI 
 
EcoRI 
XbaI 
XbaI 
 
EcoRI 
XbaI 
XbaI 
 
NotI 
XbaI 
XbaI 
 
NotI 
XbaI 
XbaI 
 
BamHI 
XbaI 
XbaI 
 
BamHI 
XbaI 
XbaI 
Primer 
Sets 
Primer Sequence 
(5’-3’) 
Restriction 
Site 
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Figure 7:  Diagram of pUB Cherry vector.  The ubiquitin 63E promoter (Ubi63E) 
was first cloned into a HindIII restriction site in the pUC19 vector.  The multiple 
cloning site (MCS) from the pIZ/V5-His vector was then cloned in using HindIII and 
NdeI restriction sites.  Finally mCherry was cloned into the piZ MCS using HindIII 
and BamHI restriction sites to give the pUB Cherry vector.  Amp – ampicillin, PAS – 
polyadenylation signal.  Note: the HindIII and XhoI sites that are found in the native 
Ubi63E promoter were destroyed to facilitate cloning.   
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Table 3: Primer sets and restriction enzymes used to generate the Drosophila 
pUB Cherry vector.  Ubi63E = ubiquitin 63 E promoter region, PizMCS = pIZ 
vector multiple cloning site. 
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this vector using the primers listed in Table 4.  A schematic of the human and 
Drosophila clones is shown in Figure 8. 
           
Generation of GFP hIntS7 Deletion Mutants 
 Nine N-terminal and nine C-terminal deletion mutants of hIntS7 were 
generated for this project.  Primers were made at approximately 100 amino acid 
intervals from the N and C-terminal ends of hIntS7 to generate a series of 
fragments, NΔ1-9 and CΔ1-9 (Table 5).  The reverse primer used to clone full-
length hIntS7 in the fluorescent-tagged clones above was used to make the N-
terminal deletion fragments, and the forward primer was used to make the C-
terminal deletion fragments (Table 4).  These fragments were then cloned into the 
N-terminal GFP vector using EcoRI and XbaI restriction sites (Figure 9). 
    
Cell Fixation and Immunofluorescence 
Human cells 
 HeLa cells were plated at 2.5×105 cells/well in 6-well plates containing cover 
slips (Fisher Scientific, Pittsburg, PA) coated with a 50µg/mL poly-D-lysine solution 
(Sigma-Aldrich, St. Louis, MO).  To coat the cover slips, the poly-D-lysine solution is 
pipetted onto the cover slips and allowed to sit for one hour.  The solution is then 
aspirated and the cover slips are dried completely.  For detection of tagged 
Integrator proteins, the cells were transfected with 100-500ng of plasmid DNA and 
incubated for 24 hours before fixation.  For cells transfected with fluorescently 
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tagged proteins, the cells were washed with phosphate buffered saline (PBS) then 
fixed in 4% paraformaldehyde (PFM; Electron Microscopy Sciences, Hatfield, PA) 
for 10 minutes.  The cells were then washed with PBS and the nucleus was stained 
with a 1:10,000 solution of DAPI in PBS for 10 minutes at 37°C.  After DAPI 
staining, the cells were washed twice with PBS and then mounted onto glass 
microscope slides using an anti-fade mounting medium (Electron Microscopy 
Sciences). 
 In cells that were probed for endogenous proteins, the cells were first 
washed and fixed in the same manner as above.  After fixing, the cells were washed 
once with PBS, and permeablized with 0.5% triton X-100 in PBS for 5 minutes. The 
cells were then washed three times with copious amounts of PBS.  After this, the 
cells were blocked with a 10% normal goat serum (NGS; Sigma-Aldrich) solution in 
PBS for 30 minutes at 37°C.  Primary antibodies, mouse α-coilin (obtained from the 
Matera Laboratory) and rabbit α-hIntS3 and α-hIntS7 (gift from Proteintech Group, 
Chicago, IL) were then added at a 1:1000 dilution and the cells incubated for 
another 30 minutes.  The cells were washed with PBS twice for five minutes at room 
temperature while rotating and then the fluorescently conjugated secondary 
antibody (α-mouse and α-rabbit AlexaFluor 555 and α-rabbit AlexaFluor 647 from 
Invitrogen) was added at 1:1000 for 30 minutes at 37°C.  The cells were then 
washed with PBS twice for five minutes while rotating.  DAPI staining and mounting 
were carried out as stated above.   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Table 4: Primer sets and restriction enzymes used to generate mCherry 
tagged Drosophila Integrator subunit clones.  All Drosophila clones have the 
mCherry tag placed on the N-terminus of the Integrator subunit. 
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dIntS2 F 
dIntS2 R 
 
dIntS3 F 
dIntS3 R 
 
dIntS5 F 
dIntS5 R 
 
dIntS6 F 
dIntS6 R 
 
dIntS7 F 
dIntS7 R 
 
dIntS9 F 
dIntS9 R 
 
dIntS10 F 
dIntS10 R 
 
dIntS12 F 
dIntS12 R 
 
dIntS13 F 
dIntS13 R 
(ASU) 
 
dIntS14 F 
dIntS14 R 
(CG4785) 
 
GGCCGGATCCAATGCCGGTGAGGATGTACGATGTATCG 
GGCCTCTAGACTAATACAGGTCCGATTTTTTCATGACCGCC 
 
GGCCGGATCCAATGGAACAGCAGCAATCAAAAAATAATGCT 
GGCCGCGGCCGCTCAGTCAGAATCATTGTTAGCTTTTTTCC 
 
GGCCGGATCCAATGCTGCGCCAGAACCTGTTGGATCAGCTTAAG 
GGCCTCTAGATTAATCTATTTCAACGATCTGCAGCCGGGCC 
 
GGCCACTAGTCATGACAATCATACTCTTCCTGGTGG 
GGCCCTCGAGTTAACTCTTGGCGACGGCCTGCTCCG 
 
GGCCACTAGTCATGTCTCACCTGACCGGCACCCGCGTG 
GGCCCTCGAGTTAAAACCTCCTCGTCTGTCCCACTG 
 
GGCCGGATCCAATGCGATTGTATTGTCTCAGCGGGGACC 
GGCCTCTAGATTAAAAACTCTGTAAGCATTTCATGATGGTGTCTC 
 
GGCCGGATCCAATGCCGAGCCAAGAGGAAAATGAGTTGTACATG 
GGCCTCTAGATCACTTAATCACAATCGTCTCCACGGGCTGAC 
 
GGCCACTAGTCATGGCCGCAAATATAGCCGCC 
GGCCTCTAGATTACTGCTTGGATCTGCGCTT 
 
GGCCGAATTCATGTTCGAACGCAACCAGAAG 
GGCCCTCGAGTTAACTACGTACGGATTC 
 
 
GGCCGAATTCATGCCCACCTTAATAGCGCTG 
GGCCCTCGAGTCAATACATGTATGCAGGAGC 
 
BamHI 
XbaI 
 
BamHI 
NotI 
 
BamHI 
XbaI 
 
SpeI 
XhoI 
 
SpeI 
XhoI 
 
BamHI 
XbaI 
 
BamHI 
XbaI 
 
SpeI 
XbaI 
 
EcoRI 
XhoI 
 
 
EcoRI 
XhoI 
Primer 
Sets 
Primer Sequence 
(5’-3’) 
Restriction 
Sites 
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Figure 8: Schematic of Drosophila and human tagged Integrator Clones.  The 
Drosophila clones contain mCherry N-terminal to the Integrator subunits, while 
human vectors were crated so that mCherry and GFP could be placed both N-
terminal and C-terminal to the Integrator subunits. 
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Table 5: Primers and restriction enzymes used to generate human IntS7 
deletion fragments.  The NΔ primers are forward primers with an EcoRI restriction 
site, and the hIntS7 full-length reverse primer with a stop codon in Table 2 was used 
with these primers.  The CΔ primers are reverse primers with an XbaI restriction 
site, and the hIntS7 full-length forward primer in Table 2 was used with these 
primers. 
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NΔ1 
 
NΔ2 
 
NΔ3 
 
NΔ4 
 
NΔ5 
 
NΔ6 
 
NΔ7 
 
NΔ8 
 
NΔ9 
 
CΔ1 
 
CΔ2 
 
CΔ3 
 
CΔ4 
 
CΔ5 
 
CΔ6 
 
CΔ7 
 
CΔ8 
 
CΔ9 
 
 
GGCCGAATTCTGTGGATGAATTTGTGAAGAGA 
 
GGCCGAATTCTGATGCAATCTTGGCTTCCAGT 
 
GGCCGAATTCTTTGTCTGTCCTTTCCACACTA 
 
GGCCGAATTCTTTAAAGATTGCTCTAAACTGT 
 
GGCCGAATTCTGTGATTGGACGATCAGCCACA 
 
GGCCGAATTCTTCAGCACTTTCTTGCATTGCT 
 
GGCCGAATTCTAAACAGTCCATGGAAGAATTT 
 
GGCCGAATTCTTATATGCACACAGCATGCCTC 
 
GGCCGAATTCTCAAAGGGTTGAACCTCATAAT 
 
GGCCTCTAGATTACTCCATCTCATTGGTCATGTT 
 
GGCCTCTAGATTAAGAAACAGGGGTATATTTCCG 
 
GGCCTCTAGATTACATCTGATTGGAGATGCGACC 
 
GGCCTCTAGATTAACTATAATTTTCCTCTTGCAA 
 
GGCCTCTAGATTACTTGTACAGCTCCATGAGGTC 
 
GGCCTCTAGATTAAGTGGCCTGAGCACCTGGACT 
 
GGCCTCTAGATTACATCCCTAGTTTTAAGCTGTC 
 
GGCCTCTAGATTAATGGTGCATGTGCTGTAGAAT 
 
GGCCTCTAGATTAATTTAGAATCTTCTCCAAATG 
Deletion Primer Sequence 
(5’-3’) 
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Figure 9: Schematic of hIntS7 deletion mutants.  Removing amino acids from 
each end in approximately 100 amino acid intervals created nine N-terminal and 
nine C-terminal deletion mutants.  All deletion mutants were cloned into the pcDNA4 
N-terminal GFP vector.  
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Drosophila Cells 
 Drosophila S2 cells were plated at 106 cells/well in 24-well plates, transfected 
with 800ng of plasmid DNA and incubated for 24-48 hours.  Cover slips (Fisher 
Scientific) were placed in a new 24-well plate and coated with a 50µg/mL 
concanavalin A (Sigma-Aldrich) solution.  The transfected S2 cells were diluted 1:6-
1:10,replated into new wells, and allowed to adhere to the concanavalin A cover 
slips for two hours.  Concanavalin A causes the S2 cells to spread on the cover slip 
were they would usually loosely attach.  The media was then removed and the cells 
were washed with PBS.  The cells were fixed with 10% PFM for 10 minutes at room 
temperature and washed again with PBS.  A 1:5000 DAPI in PBS solution was 
added and the cells were incubated at room temperature for 10 minutes to stain the 
nucleus. In my hands, increasing the concentration of DAPI and the time of 
incubation resulted in optimal DNA signal. Finally the cells were washed twice with 
PBS and mounted in the same way as the human cells. 
 All slides were visualized using the Nikon A1R Confocal Laser Microscope 
System in the Cytodynamic Imaging Facility in the Department of Integrative Biology 
and Pharmacology at the UT Medical School.  All images were taken using a 60X 
plan-Apo/1.4 NA Oil objective.  Images were processed using Adobe Photoshop.              
 
RNAi 
 Human siRNA sequences against hIntS7, 5’ GGCUAAAUAGUUUGAAGGA 
3’ and 5’ CUCUAAACUGUAUGGUGAA 3’ were purchased from Sigma-Aldrich.  To 
perform siRNA knockdown experiments, HeLa cells were plated at 1.2×105 
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cells/well in a 24-well plate.  24 hours later, the siRNA was transfected using 
Lipofectamine 2000.  Briefly, 3µL/well of siRNA and 47µL/well of Opti-MEM medium 
were mixed in tube A, and 3µL/well Lipofectamine 2000 and 12µL/well Opti-MEM 
were mixed in tube B and incubated for seven minutes at room temperature.  The 
tube were then combined and incubated for 25 minutes at room temperature.  After 
this incubation, 38µL/well of Opti-MEM was added to the transfection solution, and 
100µL was added to each well.       
To generate double stranded (dsRNA) for RNAi in Drosophila S2 cells, first, forward 
and reverse T7 primers with the sequence 5’-GGTAATACGACTCACTATAG-3’ plus 
18-30 nucleotides of gene specific sequence were designed for dIntS1-14 and 
Thread (positive control) at the positions shown in Figure 10.  The T7 templates 
were amplified using PCR, and the resulting DNA was subjected to phenol-
chloroform purification and ethanol precipitation for 15 minutes at -20°C and then 
resuspended in dH20 at approximately 1µg/µL.  These templates were then used to 
generate dsRNA via in vitro transcription.  To set up the 300µL in vitro transcription 
reaction, 9µL of 62.5 mM NTPs, 30µL 10X transcription buffer (400mM Tris (pH8), 
150mM MgCl2, 50mM DTT, 0.5 mg/mL BSA), 10µL DNA template, 1-10µL T7 RNA 
polymerase and 250µL dH20 were mixed together.  This was then incubated at 
37°C for 24 hours.  1µL of DNaseI was then added and the reaction incubated for 
30 minutes at 37°C.  After this, the reaction tubes were placed in a beaker of water 
and brought to a boil.  The reaction was boiled for 2 minutes and then cooled to 
room temperature in the water.  Once cooled, 1µL of the dsRNA was run on a 1% 
agarose gel with a dsRNA ladder to quantify; the top band of 2µL of the dsRNA  
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Figure 10: Positions of Drosophila dsRNA sequences.  Forward and reverse T7 
primers were designed to the positions shown to generate dsRNA for use in S2 
knockdown experiments.  Each dsRNA sequence is approximately 500 base pairs.  
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ladder (New England Biolabs, Ipswich, MA) equals 140ng dsRNA. To perform RNAi 
knockdown in S2 cells; cells are resuspended at 106 cells/mL and 70µL of this 
suspension is plated in 96 well plates.  The cells are then treated with 10µg/mL 
dsRNA for three days and then collected.    
 
Western Blot 
 Cells were collected and lysed for Western blot by incubating them 50-
250µL of low-salt lysis buffer for one hour.  Relative protein levels were determined 
using the Bradford assay, and all samples were normalized to the lysate containing 
the least protein.  To prepare the lysates for gel electrophoresis, up to 20µL of each 
lysate was mixed with an equal amount of 2X SDS loading buffer and boiled for five 
minutes at 95°C.  The boiled samples and protein ladder (Fermentas) were loaded 
into a 12.5% SDS polyacrylamide gel.  The samples were run at 80V through the 
stacking gel, and then the voltage was increased to 150V and the samples were run 
until the dye front ran off the bottom of the gel.  The proteins were transferred to a 
PVDF membrane overnight at 30V.  The membrane was blocked for one hour in 5% 
milk then probed with the primary antibody in 5% milk for one hour.  The primary 
antibody used in this project was the mouse α-GFP antibody, JL-8 (Clontech, 
Mountain View, CA) used at 1:5000.  The membrane was then washed three times 
for 10 minutes with 5% milk.  Next, the membrane was probed with α-mouse 
horseradish peroxidase conjugated secondary antibody (Invitrogen) at 1:5000 in 5% 
milk for one hour, and this was followed with another set of washes.  After the final  
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wash, the milk is rinsed off of the membrane with PBS, and the membrane is 
incubated for five minutes in ECL solution (Thermo Scientific, components mixed 
1:1) then placed in an autoradiography cassette.  Film is exposed to the membrane 
for <30 seconds to 10 minutes then developed. 
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Chapter 3: 
Results 
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The Localization of Integrator Subunits. 
 With the exception of IntS9 and 11, which serve as the cleavage factor for 
snRNA processing, little is known about the functions of the other Integrator 
subunits.  Determining the subnuclear localizations of these subunits could provide 
valuable clues as to the function of the Integrator subunits, therefore, mCherry and 
GFP tagged clones were generated for all the human and Drosophila Integrator 
subunits with the exception of hIntS1 and 8 as well as the human orthologues of 
Drosophila Asunder (Asu, IntS13) and CG4785 (IntS14) as cDNAs were not 
available at the time of this project.  In addition, dIntS1, 4, 6, 8, 10, and 11 which 
could not be cloned in the timeframe of this project.   
 To generate the expression vectors for the human Integrator subunits, 
mCherry and GFP cDNAs were cloned into the pcDNA4/TO/Myc-His A vector to 
create the four expression vectors: N-terminal GFP, C-terminal GFP, N-terminal 
mCherry, and C-terminal mCherry.  The rationale for creating these four constructs 
were to test and compare localization of Integrator proteins by tagging both at the 
N-terminus and C-terminus to address any tag positional effects.  Also, we used two 
fluorescence tags to address any potential artifacts associated with these fusion 
proteins. The Integrator subunits were then cloned into these vectors to generate 
Integrators that were tagged both N-terminally and C-terminally with GFP and 
mCherry.  500ng/well of these plasmids were transfected into HeLa cells plated on 
poly-D-lysine coated cover slips, which were subsequently fixed and imaged using 
confocal microscopy.  The majority of the human Integrators, hIntS4, 5, 6, 9, 10, 11, 
and 12 display no remarkable subcellular localization.  They are diffusely nuclear, 
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which we predicted given their role in snRNA 3’ end processing, a nuclear event.  
However, while still nuclear, hIntS3 was observed in discrete foci, and surprisingly, 
hIntS2 and 7 were observed to form discrete cytoplasmic foci with little expression 
seen in the nucleus (Figure 11).   
 Tagged clones of Drosophila Integrator proteins were also created for 
transfection in S2 cells.  cDNAs for the Drosophila Integrator subunits were cloned 
into the pUB Cherry expression vector constructed for this purpose by cloning the 
ubiquitin 63E promoter, pIZT/V5-His vector MCS and mCherry cDNA into the 
pUC19 vector.  This resulted in plasmids with mCherry N-terminal to the Integrator 
subunits.  800ng/well of these plasmids were transfected into S2 cells, and these 
cells were transferred 24-48 hours later onto concanavalin A coated cover slips, 
fixed and imaged using confocal microscopy.  Localizations for the Drosophila 
Integrator subunits are shown in Figure 12.  dIntS5, 6, 9, and 12 as well as Asu 
(dIntS13) and CG4785 (dIntS14) demonstrate diffuse nuclear localization as was 
expected for most subunits, and dIntS2 and 7 localized to discrete cytoplasmic foci, 
similar to hIntS2 and 7 in HeLa cells.  The nuclear foci seen with hIntS3 in HeLa 
cells were not observed with dIntS3 in S2 cells; rather, dIntS3 seems to be diffusely 
spread throughout the cell, suggesting Drosophila IntS3 does not share a similar 
localization with human IntS3.  However, S2 cells did not tolerate overexpression of 
proteins well, and it is possible that the tagged form of dIntS3 does not localize to 
nuclear foci, but the endogenous protein does. 
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Figure 11: Confocal images of human Integrator subunit localizations.  Most of 
the human Integrator subunits exhibit a diffuse nuclear localization.  The exceptions 
are hIntS2, 3, and 7.  hIntS3 forms distinct foci in the nucleus, while hIntS2 and 7 
form distinct cytoplasmic foci (arrows).  Some of the images show N-terminal GFP 
tagged Integrators and C-terminal mCherry tagged Integrators to demonstrate that 
the localizations of these tagged proteins overlap and the tags or their location on 
the protein are not the cause of the shown localizations.  Cells transfected with a 
single tagged construct yielded similar results.   
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Figure 12: Confocal images of Drosophila Integrator subunit localizations.  
Most of the Drosophila Integrator subunits display diffuse nuclear localization, 
however dIntS2 and 7 display discrete cytoplasmic foci (arrows). 
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Human IntS3 Colocalizes with Cajal Body Marker Coilin in the Nucleus. 
Given the localization of hIntS3 to nuclear foci we hypothesized that hIntS3 
could be associating with a known nuclear body such as histone locus bodies, 
nuclear speckles, or Cajal bodies.  Histone locus bodies form at the genes of 
replication dependent histones and contain biomolecules such as the U7 snRNP 
and other factors necessary for the 3’ end processing of histone mRNA [65].  
Nuclear speckles are sites of U snRNP maturation and storage; [66] while Cajal 
bodies are often observed adjacent to snRNA genes and are sites of snRNA 
transcription that have also been shown to monitor the export of snRNAs from the 
nucleus [71].  Since the Integrator complex is involved in snRNA transcription and 3’ 
end processing, we hypothesized that hIntS3 localizes to the Cajal bodies. 
Colocalization studies were carried out with coilin, a standard Cajal body 
marker to determine if our hypothesis was accurate.  First, HeLa cells transfected 
with GFP-hIntS3 were stained for endogenous coilin (Figure 13, top panel).  The 
GFP-hIntS3 foci colocalized completely with the coilin foci, implying that hIntS3 
does localize to Cajal bodies in the nucleus.  Colocalization studies staining both 
endogenous hIntS3 and coilin were also performed to confirm the localization of 
hIntS3 to Cajal bodies (Figure 13, bottom panel).  Endogenous hIntS3 forms 
nuclear foci as well, and these foci completely colocalize with coilin foci, 
corroborating the results seen with GFP-tagged hIntS3.  These results confirm our 
hypothesis that hIntS3 localizes to the Cajal bodies. 
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Figure 13: hIntS3 colocalizes with coilin.  Both the exogenous GFP tagged 
hIntS3 (top panel) protein and the endogenous hIntS3 protein (bottom panel) 
colocalize with the Cajal body protein coilin. AF – AlexaFluor 555 (red) and 647 
(green) were used to stain endogenous proteins. 
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Human and Drosophila IntS2 and 7 Colocalize with P Body Marker Dcp1 in 
Discrete Cytoplasmic Foci. 
The most interesting and unexpected finding of this project was the 
localization of IntS2 and 7 to cytoplasmic foci, and as a result, these two subunits 
became my focus.  As with hIntS3 in the nucleus, there were several cytoplasmic 
bodies considered to be possible locations for IntS2 and 7 in Drosophila and human 
cells, including stress granules, U bodies, and P bodies.  Stress granules are sites 
where mRNPs stalled in translation initiation aggregate along with initiation factors, 
the 40S ribosomal subunit, and Pab1 [97].  U bodies are cytoplasmic foci that 
contain all the U snRNPs in addition to snRNP assembly factors such as SMN, and 
are hypothesized to be sites of U snRNP assembly [100].  Finally, P bodies are 
sites of storage for translationally repressed mRNPs as well as sites of mRNA 
decapping and decay and miRNA and siRNA gene silencing [93].                            
While stress granules and P bodies are both mRNA granules, U bodies are 
predicted to play a role in U snRNP assembly and were first thought to be a likely 
localization for cytoplasmic Integrator subunits.  However, colocalization studies 
with hIntS7 and SMN performed by our collaborator, Mirek Dundr from Rosalind 
Franklin University in Chicago, Illinois showed that the two proteins do not 
colocalize (personal communication), therefore it is unlikely that IntS2 and 7 localize 
to U bodies.  We therefore predicted IntS2 and 7 localize to P bodies because 
stress granules consist solely of translationally stalled mRNPs and the Integrator 
complex has not been implicated in translation.  Additionally, it is possible that these 
Integrator subunits may play a role in the decay of U snRNAs. 
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 To determine if IntS2 and 7 localize to P bodies colocalization studies with P 
body marker Dcp1 were performed.  HeLa cells were co-transfected with 500ng of 
Cherry-hIntS2 or 7 and 500ng GFP-Dcp1 (plasmid obtained from the Shyu 
Laboratory) then fixed and imaged (Figure 14).  hIntS2 and 7 foci colocalized 
completely with Dcp1 foci, tentatively confirming our hypothesis.  Endogenous 
hIntS7 was also stained in HeLa cells (Figure 15, top panel) and this result 
confirmed the presence of hIntS7 in cytoplasmic foci.  Endogenous hIntS7 was also 
stained in HeLa cells transfected with GFP-Dcp1 and the hIntS7 foci again 
colocalized with the GFP-Dcp1 foci (Figure 15, bottom panel), further demonstrating 
the presence of hIntS7 in P bodies.  Colocalization of Drosophila IntS2 and 7 and 
Dcp1 was also performed in S2 cells co-transfected with 800ng of Cherry-dIntS2 or 
7 and 800ng of Drosophila GFP-Dcp1 (plasmid cloned by Jiandong Chen while 
rotating in the Shyu laboratory) and these two subunits were also shown to 
colocalize with Dcp1 in this model as well (Figure 16). 
  
IntS1 and 11 Are Required for IntS2 and 7 Localization to Cytoplasmic Foci in 
Drosophila S2 Cells. 
 Here, I addressed the question of the dependency of IntS2 and IntS7 
cytoplasmic foci on expression of other Integrator subunits. The interdependency of 
dIntS2 and 7 on the expression of the other Integrator subunits was explored 
through systematically knocking down each Integrator subunit and monitoring the 
effects on the localization of dIntS2 and 7 in S2 cells.  On day one, S2 cells were 
plated in a 96-well plate and treated with dsRNA to the 14 Integrator subunits as  
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Figure 14: Cherry hIntS2 and 7 colocalize with GFP Dcp1.  Both mCherry 
tagged hIntS2 and 7 colocalize with GFP tagged P body marker Dcp1.  
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Figure 15: Endogenous hIntS7 localization.  Endogenous hIntS7 localizes to 
discrete cytoplasmic foci (top panel) and these foci colocalize with GFP tagged 
Dcp1 (bottom panel). AF – AlexaFluor 555 was used to stain endogenous protein.  
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Figure 16: Cherry dIntS2 and 7 colocalize with GFP Dcp1.  mCherry tagged 
dIntS2 and 7 colocalize with GFP tagged P body marker Dcp1 (arrows).   
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well as Thread, which was used as a positive control.  On day two, the cells were 
transfected with 500ng/well of either Cherry-dIntS2 or 7, and on day three the cells 
were treated a second time with dsRNA.  Finally, on day four the cells were fixed 
and visualized using confocal microscopy.  It was found that the same two 
Integrator subunits, dIntS1 and 11 disrupted the localization of both dIntS2 and 7.  
When dIntS1 was knocked down dIntS2 was no longer expressed while dIntS11 
knockdown cause dIntS2 to localize diffusely in the nucleus.  dIntS7 was found to 
be either diffusely in the nucleus or diffusely in the cytoplasm when dIntS1 was 
knocked down, and knockdown of dIntS11 led to a diffuse cytoplasmic localization 
for dIntS7. These results are summarized in Table 6 and representative images for 
dIntS7 are shown in Figure 17.   
 The experiment was then repeated in cells transfected with Cherry dIntS2 or 
7 or GFP-Dcp1, this time knocking down only dIntS1, 11, and 12. Knocking down 
IntS12 served as a negative control as we did not see any disruption in localization 
in the previous set of experiments.  This experiment was performed in triplicate and 
the results quantified.  As expected, when dIntS12 was knocked down, no change 
was observed in the localization of dIntS2 or 7 (Figure 18).  When dIntS1 was 
knocked down Cherry-dIntS2 was localized to discrete foci in 56 ± 4% of cells.  It 
was diffusely cytoplasmic in 36 ± 4% of cells and diffusely cytoplasmic in 8 ± 4% of 
cells.  Cherry-dIntS7 was localized to discrete foci in 47 ± 11% of cells, diffusely 
cytoplasmic in 51 ± 12% of cells and diffusely nuclear in 1 ± 1% of cells (Figure 19). 
Cherry-dIntS2 was localized to discrete foci in 81 ± 3% of cells in which dIntS11 
was knocked down, diffusely cytoplasmic in 12 ± 3% of cells and diffusely nuclear in  
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Table 6: Summary of Integrator subunit knockdown experiment.  The effects of 
Integrator subunit knockdown on the localization of dIntS2 and 7 are listed.  * dIntS2 
is diffuse in the nucleus, # dIntS7 is diffuse in the nucleus or cytoplasm, ⌘ dIntS7 is 
diffuse in the cytoplasm. 
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Figure 17: Effects of Integrator subunit knockdown on dIntS7 localization.  
The localization of dIntS7 exhibits no dependence on the expression of the majority 
of the other Integrator subunits (dIntS5 knockdown shown).  However, the 
knockdown of dIntS1 produces dIntS7 localization that is either diffusely nuclear or 
cytoplasmic, and the knockdown of dIntS11 yields diffusely cytoplasmic dIntS7 
localization. 
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Figure 18: Quantification of the effects of dIntS12 knockdown on dIntS2 and 7 
localization. A. When dIntS12 is knocked down, no change in mCherry dIntS2 and 
dIntS7 and GFP Dcp1 was observed.  B. Representative images of localizations 
observed. 
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Figure 19: Quantification of the effects of dIntS1 knockdown on dIntS2 and 7 
localization.  A. When dIntS1 is knocked down, mCherry dIntS2 localized to 
discrete cytoplasmic foci in 56 ± 4% of cells, was diffusely cytoplasmic in 36 ± 4% of 
cells and was diffusely nuclear in 8 ± 4% of cells.  mCherry dIntS7 localized to 
discrete foci in 47 ± 11% of cells, was diffusely cytoplasmic in 51 ± 12% of cells and 
diffusely nuclear in 1 ± 1% of cells.  There was no change in the localization of GFP 
tagged Dcp1.  B., C., D. Representative images of localizations observed.        
 
 
 
 
 
 
 
 
 
89 
 
 
 
 
 
 
 
 
 
 
90 
7 ± 2% of cells.  Cherry-dIntS7 was in discrete foci in 80 ± 1% of cells, diffusely 
cytoplasmic in 15 ± 2% of cells and diffusely nuclear in 5 ± 1% of cells (Figure 20).  
Additionally, no change was observed in the localization of GFP-Dcp1 when any of 
the Integrator subunits were knocked down. 
   
Deletions in Human IntS7 Gene Have Little Effect on hIntS7 Localization. 
 The amino acid alignment of IntS7 shown in Figure 21 highlights two 
conserved regions in the IntS7 protein.  The first one (red box) corresponds to the 
ARM repeats which function in protein-protein interactions found in approximately 
the first 200 amino acids, and the second (blue box) is the DUF 3453, which is also 
found in Symplekin.  To determine if these domains are responsible for the 
localization of hIntS7 to cytoplasmic foci a series of deletion mutants were created 
and their localizations were compared to that of the full-length hIntS7.  Nine N-
terminal and nine C-terminal deletion mutants were generated in the GFP-N vector 
(expression shown in Figure 22 C.) and these were co-transfected into HeLa cells 
with Cherry-hIntS7 and imaged using confocal microscopy.  500ng/well of Cherr-
hIntS7 was transfected, however the amount of deletion mutant plasmid was 
adjusted to ensure even expression.  Deletion of any part of the protein led to 
stronger nuclear staining where none was observed in cells transfected with the full-
length protein.  This localization, however, was not accompanied by a loss of 
discrete cytoplasmic foci (Figure 22 A. and B.). 
 
Depletion of Human IntS7 Leads to Increased snRNA Misprocessing. 
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Figure 20: Quantification of the effects of dIntS11 knockdown on dIntS2 and 7 
localization. A. When dIntS11 is knocked down, mCherry dIntS2 localized to 
discrete cytoplasmic foci in 81 ± 3% of cells, was diffusely cytoplasmic in 12 ± 3% of 
cells and was diffusely nuclear in 7 ± 2% of cells.  mCherry dIntS7 localized to 
discrete foci in 80 ± 1% of cells, was diffusely cytoplasmic in 15 ± 1% of cells and 
diffusely nuclear in 5 ± 1% of cells.  There was no change in the localization of GFP 
tagged Dcp1.  B., C., D. Representative images of localizations observed. 
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Figure 21: Six species alignment of IntS7.  An alignment of the amino acid 
sequence of IntS7 for six species, human, cow, chicken, Xenopus, zebrafish, and 
Drosophila reveal two areas of high sequence similarity.  The first (red box) 
corresponds to the ARM repeats in the first ≈200 amino acids.  The second (blue 
box) corresponds to the DUF 3453.   
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Figure 22: GFP tagged hIntS7 deletion mutant localizations.  Deletion of any 
part of hIntS7 leads to stronger nuclear staining, however, discrete cytoplasmic foci 
are still detectable.  A. N-terminal deletions, B. C-terminal deletions, C. Western blot 
showing expression of deletion fragments. 
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 While human and Drosophila IntS2 and 7 display a cytoplasmic localization, 
it has been shown in S2 cells that depletion of these subunits leads to accumulation 
of misprocessed snRNAs, suggesting that IntS2 and 7 also play a role in the 
nucleus [38].  A humanized version of the GFP-U7 snRNA reporter used in [38] was 
developed to determine if depletion of hIntS7 effects snRNA processing in HeLa 
cells.  Two hIntS7 siRNA sequences were used in this experiment as well as a 
control siRNA sequence and the experiment was done in triplicate.  Briefly, cells 
were plated in 24-well plates and allowed to attach overnight.  Then, the cells were 
treated with siRNA once and again a second time 24 hours later.  24 hours after the 
last siRNA treatment, the cells were transfected with the GFP-U7 reporter plasmid 
and mCherry plasmid.  The next day the amount of GFP and mCherry fluorescence 
was measured in multiple locations in each well and the results quantified.  mCherry 
expression was used as a control readout and GFP expression was normalized to 
the amount of mCherry expression.  The normalized GFP expression of the test 
siRNA wells was then normalized to the control siRNA wells to derive the fold 
increase in GFP expression in hIntS7 depleted cells (Figure 23).  A 26 ± 6 fold 
increase in GFP expression was seen in cells treated with hIntS7 siRNA 7-1 and a 
13 ± 2 fold increase in GFP expression was seen in cells treated with the 7-2 
siRNA.  From these results, we concluded that depletion of hIntS7 leads to 
increased misprocessing of snRNAs in human cells as well as Drosophila cells.  
These data also suggest that IntS7 is required for the processing occurring in 
nucleus and likely resides there as well as the cytoplasm.  Additionally, in cells  
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Figure 23: Depletion of hIntS7 leads to misprocessing of snRNA in human 
cells.  Misprocessing of snRNA in HeLa cells increases 25.84 ± 5.93 fold over 
control cells (C2) when hIntS7 is knocked down with siRNA 7-1 and 13.06 ± 1.51 
fold when knocked down with siRNA 7-2 (graph).  Bottom panel shows examples 
expression of hU7-GFP reporter and mCherry for each case.   
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stained for endogenous hIntS7, staining can be observed in the nucleus along with 
the cytoplasmic foci, further confirming this conclusion (Figure 15).          
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 The purpose of this study was to paint a picture of Integrator subunit 
localization in the cell.  Between the human and Drosophila models, localizations for 
all of the subunits, with the exception of IntS1 and 8 were revealed, and 
localizations seen in one model generally held for the other.  From these images we 
conclude that the majority of the Integrators are diffusely spread across the nucleus, 
an expected result given the major function of the Integrator complex is to facilitate 
the proper 3’ end processing of snRNAs.  We also hypothesized that some of the 
subunits would localize to discrete subnuclear domains such as Cajal bodies, which 
are found adjacent to snRNA genes and are sites of snRNA transcription [50].  
Confirming this, hIntS3 was seen in discrete nuclear foci that colocalized with Cajal 
body marker coilin.  Unexpectedly, however, IntS2 and 7, in both human and 
Drosophila cells was observed in discrete cytoplasmic foci, a localization 
incompatible with the known nuclear function of the Integrator complex.  These foci 
colocalized with Dcp1 suggesting that these subunits are present in P bodies. 
 
The Localization of IntS3 in Cajal Bodies. 
The colocalization of endogenous hIntS3 and coilin confirms the presence of 
hIntS3 in Cajal bodies, however, further biochemical experiments, such as 
immunoprecipitation (IP) of IntS3 and coilin as well as IP/mass spectrometry (MS) 
of Cajal body components would provide additional support for this conclusion [37].  
While the role of IntS3 in Cajal bodies is unknown, it might function to recruit Cajal 
bodies and/or other Integrators to snRNA genes.  Interestingly, it has been shown 
that depletion of IntS3 in S2 cells has no effect on snRNA processing [38].  These 
105 
data suggest that while IntS3 might facilitate the recruitment of these factors to 
snRNA genes, processing of snRNAs is not compromised when IntS3 is depleted.  
The role of IntS3 in snRNA processing in human cells has not been formally tested 
and thus it may behave differently in human cells playing a more dominant role in 
processing. One alternative hypothesis is that IntS3 is indeed required for 
processing of snRNA but it may also be required for transcription of snRNA.  
Therefore, depletion of IntS3, unlike other Integrator subunits, would not result in 
accumulation of misprocessed snRNA but rather a depletion of processed only.  It 
would be interesting to determine if cells in which IntS3 is depleted produce less 
snRNA than cells with functioning IntS3.  Additionally, it would be useful to 
determine the fate of Cajal bodies when IntS3 is depleted.  If IntS3 is responsible for 
the recruitment of Cajal bodies to snRNA genes, depletion of IntS3 could prevent 
the localization of Cajal bodies to these sites or possibly prevent the formation of 
Cajal bodies all together. 
 
Integrators 2 and 7 Display a Conserved Phenotype of P Body Localization.  
Here, we show that mCherry tagged IntS2 and 7 colocalize with GFP tagged 
Dcp1 in both HeLa and S2 cells.  This finding was further confirmed through the 
detection of endogenous hIntS7 in P bodies.  As with IntS3, further studies should 
be completed to confirm the presence of IntS2 and 7 in P bodies that are 
biochemical in nature.  These include IP of IntS2/7 with Dcp1 and IP/MS of P body 
components as mentioned previously.  
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P bodies have been shown to be dynamic structures with molecules such as 
Dcp1 constantly entering and leaving [93].  This was determined using a technique 
called fluorescence recovery after photobleaching (FRAP) where a particular region 
is photobleached using a confocal microscope and the rate of the return of 
fluorescent molecules that that region is monitored.  This experimental technique 
has been mastered by the Dundr laboratory at Rosalind Franklin University and was 
performed with our tagged Integrator constructs by Dr. Mirek Dundr.  To determine 
if hIntS7 displays a dynamic association with P bodies similar to Dcp1 a similar 
technique called inverse (iFRAP) was used whereby the area surrounding a 
particular region is photobleached and the rate that the fluorescent molecules leave 
that region is monitored.  Cells were transfected with Cherry-hIntS7 and GFP-Dcp1, 
and iFRAP was performed on several hIntS7 and GFP foci.  We predicted that the 
association of hIntS7 with the cytoplasmic foci would be dynamic with hIntS7 
proteins slowly migrating away from the targeted foci, similar to what is seen with 
Dcp1 foci.  However, this was not the case.  While the Dcp1 foci were dynamic in 
this experiment, hIntS7 was very stable in the foci with very little protein moving 
away (Figure 24).   
 Although IntS2 and 7 appear to colocalize with Dcp1 in P bodies, the 
Integrator subunits behave differently in these structures than Dcp1 evidenced by 
the results of the iFRAP experiment described above, which demonstrates that 
hIntS7 is more stable within its foci while Dcp1 is more dynamic.  Testing the effects 
of drugs, such as, cycloheximide and RNase A, which have been shown to disrupt 
the formation of P bodies in cells, on IntS2 and 7 foci as well as the effects of  
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Figure 24: Inverse FRAP of mCherry hIntS7 and GFP Dcp1.  The Y-axis 
represents the percentage of original fluorescence immediately after iFRAP.  The 
percentage decreases over time as the GFP or mCherry-fusion protein diffuses out 
of the foci. The X-axis is a timescale of the experiment in seconds. 
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depletion of Dcp1 or other P body components would provide further insight to the 
behavior of these proteins in the cytoplasm.  
      The localization of these two proteins in P bodies was not expected. Aside from 
these structures residing in the cytoplasm where snRNA processing does not occur, 
P bodies contain many factors involved in mRNA destabilization or translational 
repression.  Thus, it is not clear what the function of Integrator subunits would be 
while in P bodies.  It is possible that they have a distinct cytoplasmic-specific 
function that is somehow relevant to mRNA decay.  Alternatively, one function that 
fits nicely with P body localization is snRNA decay.  While IntS2 and 7 do not seem 
to play a role in the decay of misprocessed snRNA, it is possible that they target 
snRNAs not properly assembled into snRNPs for decay in P bodies.  One 
hypothesis is that IntS2 and 7 remain associated with the snRNA after it is cleaved 
and exported to the cytoplasm.  Once in the cytoplasm, IntS2 and 7 monitor the 
assembly of the snRNP, and shuttles misassembled snRNP to P bodies for decay.  
Blocking nuclear export with leptomycin B, for example, would be one way to test 
this hypothesis, however, the iFRAP study suggests against the shuttling of IntS7 
between the nucleus and the cytoplasm.  It is still possible that these Integrators 
play a role in the decay of misassembled snRNPs or snRNAs exported to the 
cytoplasm, but not assembled into snRNPs.  To investigate this theory, SMN or one 
of the Sm proteins could be knocked down via RNAi and the size of the IntS2 and 7 
foci could be monitored.  Larger foci would suggest that IntS2 and 7 are shuttling 
snRNAs unable to be assembled into snRNP to the P bodies for decay.  
Additionally, in situ hybridization could be used to determine if snRNAs can be 
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detected in P bodies.  It is also possible that IntS2 and 7 in P bodies function in a 
role that is completely separate from snRNA 3’ end processing and decay.   
 While it is unknown if the disruption of Dcp1 or other P body components 
affects the expression of IntS2 and 7 in cytoplasmic foci, the depletion of Ints1 and 
11 in Drosophila S2 cells appears to reduce the number of cells with IntS2 or 7 foci.  
IntS11 is the catalytic subunit of the Integrator complex, responsible for the 3’ 
cleavage of the nascent snRNA.  Its depletion produces misprocessed snRNA in 
the cell [38] suggesting that properly processed snRNA is necessary for the 
localization of IntS2 and 7 to cytoplasmic foci.  IntS1 causes abundant 
misprocessing when depleted as well, supporting this hypothesis.  However, the 
depletion of other Integrator subunits, which also cause misprocessing when 
disrupted, had no effect on the localization of IntS2 and 7.  This discrepancy implies 
the disruption of the localization of IntS2 and 7 through the depletion of IntS1 and 
11 could be unrelated to the 3’ end processing of snRNA and these four Integrator 
subunits form a sub complex that performs an entirely different function. 
 
Domain Analysis of IntS7 with Respect to Its Cellular Localization. 
In this study we attempted to define the domain responsible for the 
localization of Ints7 to cytoplasmic foci by designing GFP tagged deletion mutants 
of hIntS7.  We hypothesized that the highly conserved ARM repeat region at the N-
terminus of the protein may be involved in the aggregation of the protein in 
cytoplasmic foci considering ARM repeats function in protein-protein interactions.  
However, this was not the case, as cytoplasmic foci could still be detected in 
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mutants in which this region was deleted.  In fact, cytoplasmic foci could be 
observed in all deletion mutants made, and we were unable to pinpoint an exact 
region responsible for the formation of foci using this method.  These foci 
colocalized with full-length hIntS7 foci; however, the deletion mutants had a strong 
nuclear presence, where the full-length protein was not seen in the nucleus.  This 
suggests that deletion of any part of the IntS7 protein causes it to be retained in the 
nucleus to a greater extent than the full-length protein.  One method in which P 
bodies are thought to assemble is through the interaction of glutamine/asparagine 
(Q/N) rich prion-like domains found in many P body components [102].  IntS7 
contains a glutamine-rich stretch at its C-terminus, which could be responsible for 
its apparent aggregation into P bodies; however, no effect was observed with the 
removal of this region in our experiment. 
 In conclusion, this study has demonstrated the cellular localization of the 
majority of the Integrator complex subunits.  As expected, we have found that one 
of the subunits, IntS3 localizes to the Cajal bodies in the nucleus.  Unexpectedly, 
however, we have shown that two of the subunits, IntS2 and 7 localize to discrete 
cytoplasmic foci that colocalize to P bodies.  This was the first time any Integrator 
subunits have been associated with these cytoplasmic structures.  These 
localizations provide clues as to the function of these Integrator subunits in snRNA 
biogenesis and snRNP assembly as well as suggest the possibility of function in 
other cellular processes.  In addition to this, this study has also generated many 
useful tools, such as the tagged Integrator clones for both human and Drosophila 
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cells, that can be used to further the understanding of the Integrator complex and its 
functions in the future.            
     
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
References 
 
 
1. Matera, A.G., R.M. Terns, and M.P. Terns, Non-coding RNAs: lessons from the 
small  nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol, 2007. 8(3): 
p. 209-20. 
2. Chen, J. and E.J. Wagner, snRNA 3' end formation: the dawn of the Integrator 
complex. Biochem Soc Trans. 38(4): p. 1082-7. 
3. Neuenkirchen, N., A. Chari, and U. Fischer, Deciphering the assembly pathway 
of Sm-class U snRNPs. FEBS Lett, 2008. 582(14): p. 1997-2003. 
4. Schumperli, D. and R.S. Pillai, The special Sm core structure of the U7 snRNP: 
far-reaching significance of a small nuclear ribonucleoprotein. Cell Mol Life 
Sci, 2004. 61(19-20): p. 2560-70. 
5. Marzluff, W.F., Metazoan replication-dependent histone mRNAs: a distinct set of 
RNA polymerase II transcripts. Curr Opin Cell Biol, 2005. 17(3): p. 274-80. 
6. Kunkel, G.R., R.L. Maser, J.P. Calvet, and T. Pederson, U6 small nuclear RNA is 
transcribed by RNA polymerase III. Proc Natl Acad Sci U S A, 1986. 83(22): 
p. 8575-9. 
7. Reddy, R., D. Henning, G. Das, M. Harless, and D. Wright, The capped U6 small 
nuclear RNA is transcribed by RNA polymerase III. J Biol Chem, 1987. 
262(1): p. 75-81. 
8. Matera, A.G., A.M. Weiner, and C.W. Schmid, Structure and evolution of the U2 
small nuclear RNA multigene family in primates: gene amplification under 
natural selection? Mol Cell Biol, 1990. 10(11): p. 5876-82. 
114 
9. Card, C.O., G.F. Morris, D.T. Brown, and W.F. Marzluff, Sea urchin small nuclear 
RNA genes are organized in distinct tandemly repeating units. Nucleic Acids 
Res, 1982. 10(23): p. 7677-88. 
10. Westin, G., J. Zabielski, K. Hammarstrom, H.J. Monstein, C. Bark, and U. 
Pettersson, Clustered genes for human U2 RNA. Proc Natl Acad Sci U S A, 
1984. 81(12): p. 3811-5. 
11. Hernandez, N., Small nuclear RNA genes: a model system to study 
fundamental mechanisms of transcription. J Biol Chem, 2001. 276(29): p. 
26733-6. 
12. Carbon, P., S. Murgo, J.P. Ebel, A. Krol, G. Tebb, and L.W. Mattaj, A common 
octamer motif binding protein is involved in the transcription of U6 snRNA by 
RNA polymerase III and U2 snRNA by RNA polymerase II. Cell, 1987. 51(1): 
p. 71-9. 
13. Hernandez, N., Formation of the 3' end of U1 snRNA is directed by a conserved 
sequence located downstream of the coding region. Embo J, 1985. 4(7): p. 
1827-37. 
14. Yuo, C.Y., M. Ares, Jr., and A.M. Weiner, Sequences required for 3' end 
formation of human U2 small nuclear RNA. Cell, 1985. 42(1): p. 193-202. 
15. Uguen, P. and S. Murphy, The 3' ends of human pre-snRNAs are produced by 
RNA polymerase II CTD-dependent RNA processing. Embo J, 2003. 22(17): 
p. 4544-54. 
16. Mandel, C.R., Y. Bai, and L. Tong, Protein factors in pre-mRNA 3'-end 
processing. Cell Mol Life Sci, 2008. 65(7-8): p. 1099-122. 
115 
17. Murthy, K.G. and J.L. Manley, The 160-kD subunit of human cleavage-
polyadenylation specificity factor coordinates pre-mRNA 3'-end formation. 
Genes Dev, 1995. 9(21): p. 2672-83. 
18. MacDonald, C.C., J. Wilusz, and T. Shenk, The 64-kilodalton subunit of the 
CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage 
site and influences cleavage site location. Mol Cell Biol, 1994. 14(10): p. 
6647-54. 
19. Callebaut, I., D. Moshous, J.P. Mornon, and J.P. de Villartay, Metallo-beta-
lactamase fold within nucleic acids processing enzymes: the beta-CASP 
family. Nucleic Acids Res, 2002. 30(16): p. 3592-601. 
20. Mandel, C.R., S. Kaneko, H. Zhang, D. Gebauer, V. Vethantham, J.L. Manley, 
and L. Tong, Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-
processing endonuclease. Nature, 2006. 444(7121): p. 953-6. 
21. Marzluff, W.F., E.J. Wagner, and R.J. Duronio, Metabolism and regulation of 
canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet, 2008. 
9(11): p. 843-54. 
22. Wang, Z.F., M.L. Whitfield, T.C. Ingledue, 3rd, Z. Dominski, and W.F. Marzluff, 
The protein that binds the 3' end of histone mRNA: a novel RNA-binding 
protein required for histone pre-mRNA processing. Genes Dev, 1996. 10(23): 
p. 3028-40. 
23. Mowry, K.L. and J.A. Steitz, Identification of the human U7 snRNP as one of 
several factors involved in the 3' end maturation of histone premessenger 
RNA's. Science, 1987. 238(4834): p. 1682-7. 
116 
24. Dominski, Z., X.C. Yang, and W.F. Marzluff, The polyadenylation factor CPSF-
73 is involved in histone-pre-mRNA processing. Cell, 2005. 123(1): p. 37-48. 
25. Kolev, N.G., T.A. Yario, E. Benson, and J.A. Steitz, Conserved motifs in both 
CPSF73 and CPSF100 are required to assemble the active endonuclease for 
histone mRNA 3'-end maturation. EMBO Rep, 2008. 9(10): p. 1013-8. 
26. Sullivan, K.D., M. Steiniger, and W.F. Marzluff, A core complex of CPSF73, 
CPSF100, and Symplekin may form two different cleavage factors for 
processing of poly(A) and histone mRNAs. Mol Cell, 2009. 34(3): p. 322-32. 
27. de Vegvar, H.E., E. Lund, and J.E. Dahlberg, 3' end formation of U1 snRNA 
precursors is coupled to transcription from snRNA promoters. Cell, 1986. 
47(2): p. 259-66. 
28. Hernandez, N. and A.M. Weiner, Formation of the 3' end of U1 snRNA requires 
compatible snRNA promoter elements. Cell, 1986. 47(2): p. 249-58. 
29. Jacobs, E.Y., I. Ogiwara, and A.M. Weiner, Role of the C-terminal domain of 
RNA polymerase II in U2 snRNA transcription and 3' processing. Mol Cell 
Biol, 2004. 24(2): p. 846-55. 
30. Medlin, J.E., P. Uguen, A. Taylor, D.L. Bentley and S. Murphy, The C-terminal 
domain of pol II and a DRB-sensitive kinase are required for 3' processing of 
U2 snRNA. Embo J, 2003. 22(4): p. 925-34. 
31. Egloff, S., D. O'Reilly, R.D. Chapman, A. Taylor, K. Tanzhaus L. Pitts, D. Eick, 
and S. Murphy, Serine-7 of the RNA polymerase II CTD is specifically 
required for snRNA gene expression. Science, 2007. 318(5857): p. 1777-9. 
117 
32. Egloff, S., S.A. Szczepaniak, M. Dienstbier, A. Taylor, S. Knight, and S. Murphy, 
The integrator complex recognizes a new double mark on the POL II CTD. J 
Biol Chem. 
33. Baillat, D., M.A. Hakimi, A.M. Naar, A. Shiatifard, N. Cooch, and R. Shiekhattar, 
Integrator, a multiprotein mediator of small nuclear RNA processing, 
associates with the C-terminal repeat of RNA polymerase II. Cell, 2005. 
123(2): p. 265-76. 
34. Egloff, S. and S. Murphy, Role of the C-terminal domain of RNA polymerase II in 
expression of small nuclear RNA genes. Biochem Soc Trans, 2008. 36(Pt 3): 
p. 537-9. 
35. Dominski, Z., X.C. Yang, M. Purdy, E.J. Wagner, and W.F. Marzlluff, A CPSF-
73 homologue is required for cell cycle progression but not cell growth and 
interacts with a protein having features of CPSF-100. Mol Cell Biol, 2005. 
25(4): p. 1489-500. 
36. Egloff, S., D. O'Reilly, and S. Murphy, Expression of human snRNA genes from 
beginning to end. Biochem Soc Trans, 2008. 36(Pt 4): p. 590-4. 
37. Malovannaya, A., Y. Li, Y. Bulynko, S.Y. Jung, Y. Wang, R.B. Lanz, B.W. 
O'Malley, and J. Qin, Streamlined analysis schema for high-throughput 
identification of endogenous protein complexes. Proc Natl Acad Sci U S A, 
2010. 107(6): p. 2431-6. 
38. Ezzeddine, N., J. Chen, B. Waltenspiel, B. Burch, T. Albrecht, M. Zhuo, W.D. 
Warren, W.F. Marzluff, and E.J. Wagner, A subset of Drosophila integrator 
118 
proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3'-end 
formation. Molecular and cellular biology, 2011. 31(2): p. 328-41. 
39. Steinmetz, E.J. and D.A. Brow, Repression of gene expression by an 
exogenous sequence element acting in concert with a heterogeneous 
nuclear ribonucleoprotein-like protein, Nrd1, and the putative helicase Sen1. 
Mol Cell Biol, 1996. 16(12): p. 6993-7003. 
40. Steinmetz, E.J., N.K. Conrad, D.A. Brow, and J.L. Corden, RNA-binding protein 
Nrd1 directs poly(A)-independent 3'-end formation of RNA polymerase II 
transcripts. Nature, 2001. 413(6853): p. 327-31. 
41. Hata, T. and M. Nakayama, Targeted disruption of the murine large nuclear 
KIAA1440/Ints1 protein causes growth arrest in early blastocyst stage 
embryos and eventual apoptotic cell death. Biochim Biophys Acta, 2007. 
1773(7): p. 1039-51. 
42. Tao, S., Y. Cai, and K. Sampath, The Integrator subunits function in 
hematopoiesis by modulating Smad/BMP signaling. Development, 2009. 
136(16): p. 2757-65. 
43. Skaar, J.R., D.J. Richar, A. Saraf, A. Toschi, E. Bolderson, L. Florens, M.P. 
Wasburn, K.K. Khanna, and W. Wang, INTS3 controls the hSSB1-mediated 
DNA damage response. J Cell Biol, 2009. 187(1): p. 25-32. 
44. Filleur, S., J. Hirsch, A. Wille, M. Schon, C. Sell, M.H. Shearer, T. Nelius, and I. 
Wieland, INTS6/DICE1 inhibits growth of human androgen-independent 
prostate cancer cells by altering the cell cycle profile and Wnt signaling. 
Cancer Cell Int, 2009. 9: p. 28. 
119 
45. Wieland, I., K.C. Arden, D. Michels, L. Klein-Hitpass, M. Bohm, C.S. Viars, and 
U.H. Weidle, Isolation of DICE1: a gene frequently affected by LOH and 
downregulated in lung carcinomas. Oncogene, 1999. 18(32): p. 4530-7. 
46. Wieland, I., C. Sell, U.H. Weidle, and P. Wieacker, Ectopic expression of DICE1 
suppresses tumor cell growth. Oncol Rep, 2004. 12(2): p. 207-11. 
47. Patel, S.B. and M. Bellini, The assembly of a spliceosomal small nuclear 
ribonucleoprotein particle. Nucleic Acids Res, 2008. 36(20): p. 6482-93. 
48. Kiss, T., Biogenesis of small nuclear RNPs. J Cell Sci, 2004. 117(Pt 25): p. 
5949-51. 
49. Will, C.L. and R. Luhrmann, Spliceosomal UsnRNP biogenesis, structure, and 
function. Curr. Opin. Cell Biol., 2001(13): p. 290-301. 
50. Frey, M.R. and A.G. Matera, Coiled bodies contain U7 small nuclear RNA and 
associate with specific DNA sequences in interphase human cells. Proc Natl 
Acad Sci U S A, 1995. 92(13): p. 5915-9. 
51. Gornemann, J., K.M. Kotovic, K. Hujer, and K.M. Neugebauer, Cotranscriptional 
spliceosome assembly occurs in a stepwise fashion and requires the cap 
binding complex. Mol Cell, 2005. 19(1): p. 53-63. 
52. Ohno, M., A. Segref, A. Bachi, M. Wilm, and L.W. Mattaj, PHAX, a mediator of U 
snRNA nuclear export whose activity is regulated by phosphorylation. Cell, 
2000. 101(2): p. 187-98. 
53. Askjaer, P., A. Bachi, M. Wilm, F.R. Bischoff, D. L. Weeks, V. Ogniewski, M. 
Ohno, C. Niehrs, K. Kjems, I.W. Mattaj, and M. Fornerod, RanGTP-regulated 
120 
interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicase. 
Mol Cell Biol, 1999. 19(9): p. 6276-85. 
54. Kitao, S., A. Segref, J. Kast, M. Wilm, I.W. Mattaj, and M. Ohno, A 
compartmentalized phosphorylation/dephosphorylation system that regulates 
U snRNA export from the nucleus. Mol Cell Biol, 2008. 28(1): p. 487-97. 
55. Kolb, S.J., D.J. Battle, and G. Dreyfuss, Molecular functions of the SMN 
complex. J Child Neurol, 2007. 22(8): p. 990-4. 
56. Battle, D.J., M. Kasim, J. Yong, F. Lotti, C.K. Lau, J. Mouaikel, Z. Zhang, K. 
Han, L. Wan, and G. Dreyfuss, The SMN complex: an assembly machine for 
RNPs. Cold Spring Harb Symp Quant Biol, 2006. 71: p. 313-20. 
57. Stark, H., P. Dube, R. Luhrmann, and B. Kastner, Arrangement of RNA and 
proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle. 
Nature, 2001. 409(6819): p. 539-42. 
58. Mouaikel, J., C. Verheggen, E. Bertrand, J. Tazi, and R. Bordonne, 
Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs 
requires a conserved methyltransferase that is localized to the nucleolus. Mol 
Cell, 2002. 9(4): p. 891-901. 
59. Plessel, G., U. Fischer, and R. Luhrmann, m3G cap hypermethylation of U1 
small nuclear ribonucleoprotein (snRNP) in vitro: evidence that the U1 small 
nuclear RNA-(guanosine-N2)-methyltransferase is a non-snRNP cytoplasmic 
protein that requires a binding site on the Sm core domain. Mol Cell Biol, 
1994. 14(6): p. 4160-72. 
121 
60. Huang, Q. and T. Pederson, A human U2 RNA mutant stalled in 3' end 
processing is impaired in nuclear import. Nucleic Acids Res, 1999. 27(4): p. 
1025-31. 
61. Kleinschmidt, A.M. and T. Pederson, Accurate and efficient 3' processing of U2 
small nuclear RNA precursor in a fractionated cytoplasmic extract. Mol Cell 
Biol, 1987. 7(9): p. 3131-7. 
62. Darzacq, X., B.E. Jady, C. Verheggen, A.M. Kiss, E. Bertrand, and T. Kiss, 
Cajal body-specific small nuclear RNAs: a novel class of 2'-O-methylation 
and pseudouridylation guide RNAs. Embo J, 2002. 21(11): p. 2746-56. 
63. Jady, B.E., X. Darzacq, K.E. Tucker, A.G. Matera, E. Bertrand, and T. Kiss, 
Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal 
body following import from the cytoplasm. Embo J, 2003. 22(8): p. 1878-88. 
64. Zhao, R., M.S. Bodnar, and D.L. Spector, Nuclear neighborhoods and gene 
expression. Curr Opin Genet Dev, 2009. 19(2): p. 172-9. 
65. Nizami, Z., S. Deryusheva, and J.G. Gall, The Cajal body and histone locus 
body. Cold Spring Harb Perspect Biol, 2010. 2(7): p. a000653. 
66. Handwerger, K.E. and J.G. Gall, Subnuclear organelles: new insights into form 
and function. Trends Cell Biol, 2006. 16(1): p. 19-26. 
67. Kiss, A.M., B.E. Jady, X. Darzacq, C. Verheggen, E. Bertrand, and T. Kiss, A 
Cajal body-specific pseudouridylation guide RNA is composed of two box 
H/ACA snoRNA-like domains. Nucleic Acids Res, 2002. 30(21): p. 4643-9. 
68. Jacobs, E.Y., M.R. Frey, W. Wu, T.C. Ingledue, T.C. Gebuhr, L. Gao, W.F. 
Marzluff, and A.G. Matera, Coiled bodies preferentially associate with U4, 
122 
U11, and U12 small nuclear RNA genes in interphase HeLa cells but not with 
U6 and U7 genes. Mol Biol Cell, 1999. 10(5): p. 1653-63. 
69. Frey, M.R. and A.G. Matera, RNA-mediated interaction of Cajal bodies and U2 
snRNA genes. J Cell Biol, 2001. 154(3): p. 499-509. 
70. Dundr, M., J.K. Ospina, M.H. Sung, S. John, M. Upender, T. Reid, G.L. Hager, 
and A.G. Matera, Actin-dependent intranuclear repositioning of an active 
gene locus in vivo. J Cell Biol, 2007. 179(6): p. 1095-103. 
71. Suzuki, T., H. Izumi, and M. Ohno, Cajal body surveillance of U snRNA export 
complex assembly. J Cell Biol, 2010. 190(4): p. 603-12. 
72. Jady, B.E., P. Richard, E. Bertrand, and T. Kiss, Cell cycle-dependent 
recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol 
Biol Cell, 2006. 17(2): p. 944-54. 
73. Tomlinson, R.L., E.B. Abren, T. Ziegler, H. Ly, C.M. Connter, R.M. Terns, and 
M.P. Terns, Telomerase reverse transcriptase is required for the localization 
of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol 
Biol Cell, 2008. 19(9): p. 3793-800. 
74. Tomlinson, R.L., T.D. Ziegler, T. Supakorudej, R.M. Terns, and M.P. Terns, Cell 
cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell, 
2006. 17(2): p. 955-65. 
75. Bongiorno-Borbone, L., A. De Cola, P. Vemole, L. Finos, D. Barcaroli, R.A. 
Knight, G. Melino, and V. De Laurenzi , FLASH and NPAT positive but not 
Coilin positive Cajal Bodies correlate with cell ploidy. Cell cycle, 2008. 7(15): 
p. 2357-67. 
123 
76. Ghule, P.N., Z. Dominski, X.C. Yang, W.F. Marzluff, K.A. Becker, J.W. Harper, 
J.B. Lian, J.L. Stein, A.J. van Wijnen, and G.S. Stein, Staged assembly of 
histone gene expression machinery at subnuclear foci in the abbreviated cell 
cycle of human embryonic stem cells. Proc Natl Acad Sci U S A, 2008. 
105(44): p. 16964-9. 
77. Liu, J.L., C. Murphy, M. Buszczak, S. Clatterbuck, B. Goodman, and J.G. Gall, 
The Drosophila melanogaster Cajal body. J Cell Biol, 2006. 172(6): p. 875-
84. 
78. Dundr, M. and T. Misteli, Biogenesis of nuclear bodies. Cold Spring Harb 
Perspect Biol, 2010. 2(12): p. a000711. 
79. Ingelfinger, D., D.J. Arndt-Jovin, R. Luhrmann, and T. Achsel, The human 
LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and 
Xrnl in distinct cytoplasmic foci. RNA, 2002. 8(12): p. 1489-501. 
80. Sheth, U. and R. Parker, Decapping and decay of messenger RNA occur in 
cytoplasmic processing bodies. Science, 2003. 300(5620): p. 805-8. 
81. Stoecklin, G., T. Mayo, and P. Anderson, ARE-mRNA degradation requires the 
5'-3' decay pathway. EMBO Rep, 2006. 7(1): p. 72-7. 
82. Fukuhara, N., J. Ebert, L. Unterholzner, D. Lindner, E. Izaurralde, and E. Conti, 
SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay 
pathway. Mol Cell, 2005. 17(4): p. 537-47. 
83. Sheth, U. and R. Parker, Targeting of aberrant mRNAs to cytoplasmic 
processing bodies. Cell, 2006. 125(6): p. 1095-109. 
124 
84. Unterholzner, L. and E. Izaurralde, SMG7 acts as a molecular link between 
mRNA surveillance and mRNA decay. Mol Cell, 2004. 16(4): p. 587-96. 
85. Lykke-Andersen, J. and E. Wagner, Recruitment and activation of mRNA decay 
enzymes by two ARE-mediated decay activation domains in the proteins TTP 
and BRF-1. Genes Dev, 2005. 19(3): p. 351-61. 
86. Liu, J., F.V. Rivas, J. Wohlschlegel, J.R. Yates III, R. Parker, and G.J. Hannon, 
A role for the P-body component GW182 in microRNA function. Nat Cell Biol, 
2005. 7(12): p. 1261-6. 
87. Liu, J., M.A. Valencia-Sanchez, G.J. Hannon, and R. Parker, MicroRNA-
dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell 
Biol, 2005. 7(7): p. 719-23. 
88. Sen, G.L. and H.M. Blau, Argonaute 2/RISC resides in sites of mammalian 
mRNA decay known as cytoplasmic bodies. Nat Cell Biol, 2005. 7(6): p. 633-
6. 
89. Andrei, M.A., D. Ingelfinger, R. Heintzmann, T. Achsel, R. Rivera-Pomar, and R. 
Luhrmann, A role for eIF4E and eIF4E-transporter in targeting mRNPs to 
mammalian processing bodies. RNA, 2005. 11(5): p. 717-27. 
90. Ferraiuolo, M.A., S. Basak, J. Dostie, E.L. Murray, D.R. Schoenberg, and N. 
Sonenberg, A role for the eIF4E-binding protein 4E-T in P-body formation 
and mRNA decay. J Cell Biol, 2005. 170(6): p. 913-24. 
91. Yedavalli, V.S., C. Neuveut, Y.H. Chi, L. Kleiman, and K.T. Jeang, Requirement 
of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell, 
2004. 119(3): p. 381-92. 
125 
92. Beckham, C.J. and R. Parker, P bodies, stress granules, and viral life cycles. 
Cell Host Microbe, 2008. 3(4): p. 206-12. 
93. Balagopal, V. and R. Parker, Polysomes, P bodies and stress granules: states 
and fates of eukaryotic mRNAs. Curr Opin Cell Biol, 2009. 21(3): p. 403-8. 
94. Eulalio, A., I. Behm-Ansmant, D. Schweizer, and E. Izaurralde, P-body 
formation is a consequence, not the cause, of RNA-mediated gene silencing. 
Mol Cell Biol, 2007. 27(11): p. 3970-81. 
95. Decker, C.J., D. Teixeira, and R. Parker, Edc3p and a glutamine/asparagine-
rich domain of Lsm4p function in processing body assembly in 
Saccharomyces cerevisiae. J Cell Biol, 2007. 179(3): p. 437-49. 
96. Savas, J.N., A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. 
Shiekhattar, S.P. Markey, and N. Tanese, Huntington's disease protein 
contributes to RNA-mediated gene silencing through association with 
Argonaute and P bodies. Proc Natl Acad Sci U S A, 2008. 105(31): p. 10820-
5. 
97. Anderson, P. and N. Kedersha, Stress granules: the Tao of RNA triage. Trends 
Biochem Sci, 2008. 33(3): p. 141-50. 
98. Gilks, N., N. Kedersha, M. Ayodele, L. Shen, G. Stoecklin, L.M. Dember, and P. 
Anderson, Stress granule assembly is mediated by prion-like aggregation of 
TIA-1. Mol Biol Cell, 2004. 15(12): p. 5383-98. 
99. Tourriere, H., K. Chebli, L. Zekri, B. Courselaud, J.M. Blanchard, E. Bertrand, 
and J. Tazi, The RasGAP-associated endoribonuclease G3BP assembles 
stress granules. J Cell Biol, 2003. 160(6): p. 823-31. 
126 
100. Liu, J.L. and J.G. Gall, U bodies are cytoplasmic structures that contain 
uridine-rich small nuclear ribonucleoproteins and associate with P bodies. 
Proc Natl Acad Sci U S A, 2007. 104(28): p. 11655-9. 
101. Akbari, O.S., D. Oliver, K. Eyer, and C.Y. Pai, An Entry/Gateway cloning 
system for general expression of genes with molecular tags in Drosophila 
melanogaster. BMC Cell Biol, 2009. 10: p. 8. 
102. Reijns, M.A., R.D. Alexander, M.P. Spiller, and J.D. Beggs, A role for Q/N-rich 
aggregation-prone regions in P-body localization. J Cell Sci, 2008. 121(Pt 
15): p. 2463-72. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
Vita 
 
Sarah Beth May was born on November 16, 1984 in Waco, Texas to Jeffrey and 
Margaret May.  She grew up in Mexia, Texas, and in May of 2003 she graduated 
Valedictorian from Mexia High School.  In August of 2003 she enrolled at The 
University of Texas at Arlington in Arlington, Texas, and graduated from that 
institution Magna cum Laude with a Bachelors of Science degree in microbiology in 
August of 2006.  In August of 2007 she enrolled in the Graduate School of 
Biomedical Sciences at The University of Texas Health Science Center in Houston, 
Texas. 
